BIOBANX INVENTORY

Sample Subtype :

Acute Leptospira

Matrix Subtype :

Plasma, Plasma Na Citrate, Plasma EDTA K3

Available Clinical Data:

Tropical Disease Other Signs and Symptoms, Tropical Disease Signs and Symptoms

Available Tests:

HAV RT-PCR, UltraQual 1000 2x

Sample Subtype :

Albumin

Matrix Subtype :

Plasma, Serum

Available Clinical Data:

Date of Birth, Lipemia (laboratory evidence), Reported Age, Elevated albumin (Alb) (laboratory evidence), Date of Draw, Ethnicity, Subject is 18 years of age or older at the time of enrollment and blood draw, Alcoholic cirrhosis (clinical diagnosis and/or laboratory evidence), Date of Consent, Time of Draw, Date of Diagnosis, Gastroenterology Condition, Country of Origin, Elevated alanine amino transferase (ALT) (laboratory evidence), City of Origin, Gender, Subject receiving treatment, Current Medications or Treatments 1, Medication Start Date, Date of onset of first symptoms

Available Tests:

Triglycerides, HDL, Albumin, Cholesterol

Sample Subtype :

Alcoholic Cirrhosis

Matrix Subtype :

Plasma, Serum

Available Clinical Data:

Date of Birth, Lipemia (laboratory evidence), Reported Age, Elevated albumin (Alb) (laboratory evidence), Date of Draw, Ethnicity, Subject is 18 years of age or older at the time of enrollment and blood draw, Alcoholic cirrhosis (clinical diagnosis and/or laboratory evidence), Date of Consent, Time of Draw, Date of Diagnosis, Country of Origin, Elevated alanine amino transferase (ALT) (laboratory evidence), City of Origin, Gender, Subject receiving treatment

Available Tests:

NT-Pro BNP

Sample Subtype :

ALD

Matrix Subtype :

Plasma, Plasma EDTA K3

Available Clinical Data:

Date of Birth, Fibrosis Score (Choose One), Date of Draw, Ethnicity, Periportal Necroinflammatory Score (Choose one), Abbott Architect Anti HCV Result, Portal Inflammation Score (Choose one), Date sample frozen at -20 C or colder, Is the most recent liver biopsy result available?, Gender, Scoring System: Focal (Spotty) Lobular Necrosis and Hepatocellular Apoptosis Score (Choose one), Scoring System: Bridging and Confluent Necrosis Score (Choose One), Sample Storage Temperature

Available Tests:

Total Protein, Total Bilirubin, Abbott Anti-HCV, Abbott HIV Ag/AB Combo, AST, Abbott HBsAg Qualitative, ALT, Abbott Syphilis TP

Sample Subtype :

ALP

Matrix Subtype :

Serum

Sample Subtype :

Cockroach, Mold

Matrix Subtype :

Serum

Available Tests:

Immulite Allergy IgE

Sample Subtype :

ALT

Matrix Subtype :

Plasma, Serum

Available Clinical Data:

Date of Birth, Lipemia (laboratory evidence), Reported Age, Elevated albumin (Alb) (laboratory evidence), Date of Draw, Ethnicity, Subject is 18 years of age or older at the time of enrollment and blood draw, Alcoholic cirrhosis (clinical diagnosis and/or laboratory evidence), Date of Consent, Time of Draw, Date of Diagnosis, Gastroenterology Condition, Country of Origin, Elevated alanine amino transferase (ALT) (laboratory evidence), City of Origin, Gender, Subject receiving treatment, Current Medications or Treatments 1, Medication Start Date, Date of onset of first symptoms

Available Tests:

T3, AST, ALT

Sample Subtype :

ANA

Matrix Subtype :

Plasma, Serum, Plasma EDTA K3

Available Clinical Data:

Date of Birth, Reported Age, Date of Draw, Ethnicity, Rheumatology Condition, Date of Consent, Start Date of Medications, Time of Draw, Date of Diagnosis, Treatment History, Country of Origin, City of Origin, Gender, Concomitant Medications (if reported)

Available Tests:

Triglycerides, dsDNA AB, Rheumatoid Factor, Total Protein, ANA IgG, SM AB, Total Bilirubin, Immunoglobulin G, SSA AB, NT-Pro BNP, Chloride (Cl), Abbott Anti-HCV, Potassium (K), Anti-Nuclear Antibodies (ANA), IgG by ELISA, Abbott HIV Ag/AB Combo, Abbott HBsAg Qualitative, SCL70 AB, CHROMATIN AB, Albumin, Cholesterol, Direct Bilirubin, Phosphorus, SSB AB, Calcium, ANA, JO1-IGG- AB, CENTROMERE AB, Cyclic Citrullinated Peptide (CCP) Antibody, IgG, RNP AB, Sodium (NA)

Sample Subtype :

Anti-Thyroglobulin

Matrix Subtype :

Serum

Available Tests:

Thyroglobulin

Sample Subtype :

AST

Matrix Subtype :

Serum, Plasma EDTA K3

Available Tests:

Abbott Anti-HCV, Abbott HIV Ag/AB Combo, AST, Abbott HBsAg Qualitative

Sample Subtype :

Asymptomatic

Matrix Subtype :

Serum SST, Nasopharyngeal swabs, Oropharyngeal Swab, Nasal Swab, Plasma EDTA K3

Available Clinical Data:

Date of Birth, COVID-19 Vaccination Date, First Dose, Reported Age, COVID-19 Vaccination Date, Second Dose, Date of Draw, Ethnicity, Vaccine manufacturer, Date of Consent, Pre-Existing Medical Conditions, Time of Draw, Country of Origin, Date sample frozen at -20 C or colder, City of Origin, Gender, If pregnant, which trimester?, Did the subject receive a covid-19 vaccination, Concomitant Medications (if reported), Time Frozen at -20 C or colder

Available Tests:

EURORealTime SARS-CoV-2, Perkin Elmer SARS-CoV-2 SWAB, AdviseDx SARS-CoV-2 IgM, Architect SARS-CoV-2 IgG

Sample Subtype :

Guillain-Barre

Matrix Subtype :

Plasma, Plasma EDTA K3

Sample Subtype :

Scl-70, RNP, Jo-1, ds-DNA, TG, SSB, Hypothyroidism, Hyperthyroidism, SM, Autoimmune Hep., SSA, MPO

Matrix Subtype :

Plasma, Serum, Serum SST, Plasma EDTA K3

Available Clinical Data:

Date of Birth, COVID-19 Vaccination Date, First Dose, Reported Age, COVID-19 Vaccination Date, Second Dose, Fibrosis Score (Choose One), Smoking History, Date of Draw, Ethnicity, Periportal Necroinflammatory Score (Choose one), Vaccine manufacturer, Subject is 18 years of age or older at the time of enrollment and blood draw, Test Date (site reported results), Date of Consent, Abbott Architect Anti HCV Result, Pre-Existing Medical Conditions, Time of Draw, Date of Diagnosis, Portal Inflammation Score (Choose one), Did subject receive a covid-19 vaccine booster?, Covid-19 vaccine booster Manufacturer, Country of Origin, Date sample frozen at -20 C or colder, City of Origin, Is the most recent liver biopsy result available?, Drug use?, Signs and Symptoms at the Time of Draw., Gender, Liver Biopsy Date Tested:, Scoring System: Focal (Spotty) Lobular Necrosis and Hepatocellular Apoptosis Score (Choose one), Did the subject receive a covid-19 vaccination, Concomitant Medications (if reported), Current Medications or Treatments 1, Scoring System: Bridging and Confluent Necrosis Score (Choose One), Time Frozen at -20 C or colder, Site reported laboratory results, Date of Covid-19 vaccine booster, Sample Storage Temperature

Available Tests:

dsDNA AB, SM AB, Thyroglobulin, Antineutrophil cytoplasmic antibodies, SSA AB, AST, SCL70 AB, ALT, SSB AB, JO1-IGG- AB, RNP AB

Sample Subtype :

BV

Matrix Subtype :

Aptima Vaginal Swab

Available Tests:

Aptima Trichomonas vaginalis Assay, Candida Vaginitis, Gardnerella vaginalis

Sample Subtype :

Bilirubin-Total

Matrix Subtype :

Serum, Plasma EDTA K3

Sample Subtype :

Bilirubin-Direct

Matrix Subtype :

Serum

Available Tests:

T3-TOTAL, Direct Bilirubin

Sample Subtype :

Blood Donor

Matrix Subtype :

Plasma

Sample Subtype :

Blood Urea Nitrogen

Matrix Subtype :

Serum

Sample Subtype :

Cadaveric

Matrix Subtype :

Plasma, Serum, Plasma EDTA K2, Serum SST, Plasma EDTA K3

Available Clinical Data:

Date of Birth, Reported Age, Date of Draw, Ethnicity, Sample Hemolysis Level (Qualtex Color Comparator), Time Between Death and Blood Draw (Minutes), Time of Draw, Transfusion and/or Infusion of blood or colloids in excess of 2,000mL within 48 hours prior to collection of the blood specimen?, Country of Origin, Date sample frozen at -20 C or colder, If transfusion or infusion of blood or colloids is less than 2,000mL, how many mL?, Time of Death, Gender, Transfusion and/or Infusion of crystalloids in excess of 2,000mL within 1 hours prior to collection of the blood specimen?, Date of Death, Cause of Death, Time Frozen at -20 C or colder, If transfusion and/or infusion of crystalloids in less than 2,000mL, how many mL?

Available Tests:

Genetic Systems HBsAg EIA 3.0, Trypanosoma cruzi, IgG, CMV Antibody IgG, Hologic Panther SARS-CoV-2, Hepatitis C Virus Antibody by CIA, Procleix Ultrio Elite Assay, Hepatitis B Core Antibodies, Total, Abbott Anti-HCV, HIV-1/HCV/HBV Ultrio Screen, Human T-Lymphotropic Virus (HTLV) Types I/II Antibodies by ELISA, Liaison CMV IgG, Aptima Zika Virus Assay - Serum, Human T-Lymphotropic Virus Types I/II Antibodies, Western Blot, Abbott HIV Ag/AB Combo, Abbott HBsAg Qualitative, Abbott Syphilis TP, HIV 1/2 ab, Trypanosoma cruzi, IgM, Hepatitis B Virus Surface Antigen, CMV Antibody IgM, Treponema pallidum Ab by TP-PA, Anti-HCV EIA: (Ortho HCV 3.0 EIA Test System), Aptima Zika Virus Assay - Plasma, Hepatitis B Virus Surface Antibody, Human Immunodeficiency Virus (HIV) Combo Antigen/Antibody (HIV-1/O/2) by CIA, WNV-PCR: (Roche WNV-PCR), Abbott Anti-HBs (AUSAB)

Sample Subtype :

Calcium, Cadaveric

Matrix Subtype :

Serum, Plasma EDTA K3

Available Clinical Data:

Reported Age, Date of Draw, Ethnicity, Time Between Death and Blood Draw (Minutes), Time of Draw, Transfusion and/or Infusion of blood or colloids in excess of 2,000mL within 48 hours prior to collection of the blood specimen?, Country of Origin, Date sample frozen at -20 C or colder, If transfusion or infusion of blood or colloids is less than 2,000mL, how many mL?, Time of Death, Gender, Transfusion and/or Infusion of crystalloids in excess of 2,000mL within 1 hours prior to collection of the blood specimen?, Date of Death, Cause of Death, Time Frozen at -20 C or colder, If transfusion and/or infusion of crystalloids in less than 2,000mL, how many mL?

Available Tests:

HIV-1/HCV/HBV Ultrio Screen

Sample Subtype :

Cancer, Gastric Cancer, Uterine Cancer, Breast Cancer, Serosa Cancer, Intestine Cancer, Larynx Cancer, Esophageal Cancer, Testicular Cancer, Salivary Gland Cancer, Liver Cancer, Cervical Cancer, Lung Cancer, Kidney Cancer, Bladder Cancer, GEJ, Thyroid Cancer, Head and Neck Cancer, Sarcoidosis, Bone Cancer, Colon Cancer, Abdominal Cancer, Rectal Cancer, Prostate Cancer, Lymphoma, AML, Lymph Node, Pelvic Tumor, Stomach Cancer, Gallbladder Cancer, Skin Cancer, Brain Cancer, Colorectal Cancer, Pancreatic Cancer, Ovarian Cancer, Cholangiocarcinoma, Endometrium Cancer, Melanoma, Penile Cancer, NSCLC

Matrix Subtype :

FFPE Tumor, Buffy Coat, WB PAXgene RNA, Plasma, Serum, WB EDTA K2, Whole Blood, Plasma cf-DNA, FFPE NAT, FFPE Metastasis, Slides, Buffy Coat cf-DNA, Plasma EDTA K3, Fresh Frozen Tissue, FFPE Tumor Curls

Available Clinical Data:

Donor HCV Status, Date of Birth, Presence of metastasis (M), Extent of spread to the lymph nodes (N), Blast Count before Treatment, Reported Age, Donor HBV Status, Date of Tissue Procurement, Date of Surgery, Description of Diagnosis, Tumor Description, Smoking History, Date of Draw, Gross Description, Ethnicity, Extent of the tumor (T), Surgical Procedure, Patient Outcome Data, Minutes before fixation to Formalin, Height (cm), Donor Syphilis Status, FFPE Tumor from Primary Tumor Resection?, Months Pregnant?, Donor HIV Status, Does the subject smoke?, Date of Blast Count after Treatment, Tumour Location, Lymph Node metastasis, Tissue Size (cm), Blast Count After Treatment, Stage of Cancer, Pre-Existing Medical Conditions, Time of Draw, Date of Diagnosis, Treatment History, Tumor Size (cm), Specimen Type, Pathology Report, Tumor Content (%), Distant metastasis location, Storage Start Date, Date of Blast Count before Treatment, Clinical Diagnosis, Country of Origin, Metastasis, Type of Collection Tube, Other Notes, Percent Necrosis, Drug use?, Current Medications (oncology), Histologic Type, Diagnosis (Oncology), Alcohol use?, Method of Verification, AML Diagnosis Test, Time of Tissue Procurement, Gender, Grade of Cancer, If pregnant, which trimester?, Cancer Related Markers, Hormonal therapy?, Date of Procedure, Concomitant Medications (if reported), Start time of blood processing, Blood Testing, Storage Start Time, Current Medications or Treatments 1, Surgical History, Pathological Diagnosis, comorbidities?, Date of Procurement, Primary or recurrent, ROS1 IHC Score, Weight, kg, Time Frozen at -20 C or colder, Site reported laboratory results, Previous Chemotherapy?

Available Tests:

Abbott Anti-HCV, Microsatellite Instable, Abbott HIV Ag/AB Combo, Abbott HBsAg Qualitative, Tissue Quality Check, DIDO1, Abbott Syphilis TP, HIV 1/2 ab, DID07, ACVR2A, SULF2, MRE11, BTBD7, RYR3, SEC31A

Sample Subtype :

Carbon Dioxide

Matrix Subtype :

Serum

Sample Subtype :

Cardiac

Matrix Subtype :

WB EDTA K2, Whole Blood

Available Clinical Data:

Date of Draw, ACE inhibitors or ARBs, Beta Blockers, Cardiovascular Disease Event (CVD), Start Date of Medications, Clot preventing drugs, Date of Cardiovascular Disease Event (CVD), Statins, Other General Medications, Surgical History

Sample Subtype :

CSF

Matrix Subtype :

CSF

Available Clinical Data:

Clinical Diagnosis

Available Tests:

dsDNA AB, Lactic Acid Dehydrogenase, Total Protein, Rubella IgM, Carcinoembryonic antigen (CEA), ANA IgG, Cell Count, HTLV I/II, CMV IgM, HSV-2 IgM, ENA-6 Panel, Treponema, Alpha-Fetoprotein, HSV-1 IgG, Anti-Glomerular Basement Membrane Disease IgG, HBsAg, HAV IgG, Aspergillus Galactomannan Ag, CMV IgG, HBV, HBeAg, Toxoplasma IgG, HSV-2 IgG, Rubella IgG, HIV, P-anca, HIV 1/2 ab, PSA (Prostatic Specific Antigen), EBV VCA IgG, CA-125, Toxoplasma IgM, ANA, EBV IgM, Hepatitis B Core Ab, CA19-9, HSV-1 IgM

Sample Subtype :

Chagas

Matrix Subtype :

Saliva, Plasma, Serum, Whole Blood, Urine

Available Clinical Data:

Subject is 18 years of age or older at the time of enrollment and blood draw, Tropical Disease Other Signs and Symptoms, Pregnant?, Suspected Tropical Disease, Tropical Disease Signs and Symptoms, Date of onset of first symptoms

Available Tests:

Trypanosoma cruzi, IgG, Chagatest HAI, DiaSorin Zika IgM, Anti-T. cruzi EIA: (Ortho T. cruzi ELISA Test System), Abbott Anti-HCV, InBios Zika IgM Capture, DiaPro Zika Virus IgG, Aptima Zika Virus Assay - Serum, InBios Anti-Dengue IgM, InBios Anti-Dengue IgG, DiaPro Anti-Chikungunya IgG, Abbott HIV Ag/AB Combo, Abbott HBsAg Qualitative, InBios Chikungunya IgM, Abbott Syphilis TP, Trypanosoma cruzi, IgM

Sample Subtype :

Chloride

Matrix Subtype :

Serum

Available Tests:

Chloride (Cl)

Sample Subtype :

Cholesterol

Matrix Subtype :

Serum

Sample Subtype :

CMV IgM, CMV, CMV IgG

Matrix Subtype :

Plasma, Serum, Plasma EDTA K2, Plasma EDTA K3

Available Clinical Data:

Reported Age, Date Treatment or Medication 1 Began, Date of Draw, Ethnicity, Date Treatment or Medication 2 Ended, Height (cm), Current Medications or Treatments 2, Time of Draw, Storage Start Date, Country of Origin, Date Treatment or Medication 1 Ended, Gender, Concomitant Medications (if reported), Start time of blood processing, Current Medications or Treatments 1, Storage Start Time, Weight, kg, Date Treatment or Medication 2 Began

Available Tests:

CMV PCR, Anti-Mullerian Hormone, CMV IgM, Abbott Anti-HCV, CMV IgG, Abbott HIV Ag/AB Combo, Abbott HBsAg Qualitative, Abbott Syphilis TP, CMV Antibody IgM

Sample Subtype :

COVID-19 Vaccination, COVID-19 Symptomatic, COVID-19

Matrix Subtype :

Serum Non-SST, SalivaBio Saliva, Saliva, WB EDTA K3, WB PAXgene RNA, Plasma, Serum, Whole Blood, DBS (Finger Prick), Serum SST, Nasopharyngeal swabs, Dry NP Swab, Norgen OP Swab, Oropharyngeal Swab, Saline, Spectrum DNA Saliva, OraSure Saliva, Nasal Swab, DBS (Venous), Plasma Na Citrate, DNA Genotek Saliva, UTM, Plasma EDTA K3, VTM NPS

Available Clinical Data:

pangoLEARN version, Date Mechanical Ventilation Stopped, SARS-CoV-2 Variant Common Name, Date of Birth, Total days with supplemental oxygen, If yes, specify illness, COVID-19 Vaccination Date, First Dose, Nucleotide Substitutions, Reported Age, Date DBS finger prick frozen at -20 C or colder, SARS-CoV-2 PANGOLIN Lineage, Did the subject Receive invasive Ventilation, Change in Concomitant Medications?, Symptomology at the Time of Diagnosis, COVID-19 Vaccination Date, Second Dose, Test Manufacturer, Date of ICU Admission, Date of Draw, Time of Centrifugation, Did the subject receive supplemental oxygen?, Ethnicity, Did the Subject Receive Other Therapeutic Interventions?, Sample Hemolysis Level (Qualtex Color Comparator), Was the subject attending rehabilitation sessions?, Vaccine manufacturer, Did the subject have acute respiratory distress syndrome, Patient Outcome Data, Did the subject develop pneumonia, Location of the Worker's Health Center, COVID-19 Molecular Test Manufacturer, Percent of Genome Coverage, Nucleotide Insertions, Did the subject Receive non-invasive Ventilation (NIV), Was the subject admitted to the intensive care unit (ICU)?, Test Date (site reported results), SARS-CoV-2 Nextstrain Clade, Date of Symptom Resolution, Did the subject have a multi organ system effect due to COVID-19?, If yes, total days with NIV, Date of Consent, Amino Acid Substitutions, Amino Acid Deletions, Oropharyngeal swab collection time, Did the subject develop longer effects of COVID-19 treatment or hospitalization?, Date of Discharge from ICU, Did the subject receive ECMO, Did the subject's symptoms resolve?, Pre-Existing Medical Conditions, Time of Draw, In the 14 days prior to illness onset, did the subject have any of the following exposures?, Date of Diagnosis, Time of DBS finger prick, Did subject receive a covid-19 vaccine booster?, Country of Origin, Saliva collection time, Date sample frozen at -20 C or colder, City of Origin, Did the subject receive Mechanical Ventilation (MV) / Intubation?, Signs and Symptoms at the Time of Draw., Was the subject previously diagnosed with COVID-19?, Was the subject diagnosed with COVID-19 since the last visit?, Time of DBS venous, Sequencing reference genome (GenBank Accession), Gender, Was the subject hospitalized?, Time of finger prick, Did the subject have another diagnosis or etiology for their illness?, If pregnant, which trimester?, Date of hospitalization, Did the subject have an abnormal EKG, Fever Temperature (F), Nucleotide Deletions, Did the subject receive a covid-19 vaccination, Concomitant Medications (if reported), Is the subject a healthcare worker?, Did the subject have an abnormal Chest X-ray, Time DBS finger prick frozen at -20 C or colder, Date of Death, Nasopharyngeal swab collection time, Date of onset of first symptoms, Time DBS venous frozen at -20 C or colder, Date DBS venous frozen at -20 C or colder, Time Frozen at -20 C or colder, Date of discharge from hospital?, Change in underlying medical conditions and/or risk behavior?, Site reported laboratory results, Day(s) subject received mechanical ventilation (MV) / Intubation

Available Tests:

PolioVirus Antibody Type 3, Bordetella pertussis Antibody, IgG by Immunoblot, Hologic Panther SARS-CoV-2, NovaTek RSV IgG ELISA, LIAISON XL SARS-CoV-2 S1/S2, InBios SARS-CoV-2 IgG, Hepatitis C Virus Antibody by CIA, Liaision SARS-CoV-2 Ab, Coxsackie B Virus Antibody Type 3, Influenza A Virus Antibody IgM, Coxsackie B Virus Antibody Type 6, Mycoplasma Pneumoniae Antibody IgM, EuroImmun COVID-19 IgG, Echovirus Antibody Type 7, Adenovirus Antibody, Serum, Influenza B Virus Antibody IgM, Echovirus Antibody Type 11, Abbott Anti-HCV, Echovirus Antibody Type 6, GeneXpert SARS-CoV-2, Liaison SARS-CoV-2 IgM, TaqPath SARS-CoV-2, B. pertussis Ab, IgA by ELISA, Echovirus Antibody Type 30, Mycoplasma Pneumoniae Antibody IgG, EDI COVID-19 IgM, Bordetella pertussis Antibody, IgM by Immunoblot, Abbott HIV Ag/AB Combo, Abbott HBsAg Qualitative, EuroImmun COVID-19 IgA, B. pertussis Ab, IgM by ELISA, InBios SARS-CoV-2 IgM, Coxsackie A9 Virus Antibodies, NovaTek Parainfluenza Virus 1, 2, 3 IgG, cPass™ SARS-CoV-2 Neutralization kit., Influenza A Virus Antibody IgG, HIV 1/2 ab, Influenza B Virus Antibody IgG, Perkin Elmer SARS-CoV-2 SWAB, Coxsackie B Virus Antibody Type 5, Abbott Architect Procalcitonin, Coxsackie B Virus Antibody Type 1, Hepatitis B Virus Surface Antigen, PolioVirus Antibody Type 1, Perkin Elmer SARS-CoV-2 SALIVA, Echovirus Antibody Type 9, Coxsackie B Virus Antibody Type 2, AdviseDx SARS-CoV-2 IgM, Bordetella pertussis Antibody, IgA by Immunoblot, Architect SARS-CoV-2 IgG, Coxsackie B Virus Antibody Type 4, Haemophilus influenzae b Antibody, IgG, Human Immunodeficiency Virus (HIV) Combo Antigen/Antibody (HIV-1/O/2) by CIA, Syphilis

Sample Subtype :

Creatinine, COVID-19

Matrix Subtype :

Serum, Serum SST

Available Clinical Data:

Date of Birth, Reported Age, Symptomology at the Time of Diagnosis, Date of Draw, Ethnicity, Location of the Worker's Health Center, Test Date (site reported results), Date of Consent, Pre-Existing Medical Conditions, Time of Draw, In the 14 days prior to illness onset, did the subject have any of the following exposures?, Country of Origin, City of Origin, Did the subject receive Mechanical Ventilation (MV) / Intubation?, Signs and Symptoms at the Time of Draw., Gender, Was the subject hospitalized?, If pregnant, which trimester?, Date of hospitalization, Fever Temperature (F), Concomitant Medications (if reported), Is the subject a healthcare worker?, Date of onset of first symptoms, Time Frozen at -20 C or colder, Date of discharge from hospital?, Day(s) subject received mechanical ventilation (MV) / Intubation, Site reported laboratory results

Available Tests:

LIAISON XL SARS-CoV-2 S1/S2, AdviseDx SARS-CoV-2 IgM, Architect SARS-CoV-2 IgG

Sample Subtype :

Crohns Disease

Matrix Subtype :

Serum SST, Plasma EDTA K3

Available Clinical Data:

Date of FCP Result, If on medications, for how long? (days), Date of Birth, Ethnicity (hispanic specific), Reported Age, Date of Draw, Ethnicity, Prior Biologic Treatment History, Date of CRP result, Subject is 18 years of age or older at the time of enrollment and blood draw, What medication(s) is the subject currently taking?, Most recent Fecal Calprotectin (FCP) result, Date of Consent, Time of Draw, Date of Diagnosis, Gastroenterology Condition, Disease Status at time of sample collection, Clinical Symptom Score (CD: CDAI), Country of Origin, Date sample frozen at -20 C or colder, City of Origin, Most recent C-reactive protein (CRP) result, Gender, Time Frozen at -20 C or colder, Is the subject currently on medications?

Sample Subtype :

Cryptococcus

Matrix Subtype :

Serum

Sample Subtype :

CMV

Matrix Subtype :

Plasma

Sample Subtype :

Symp. DNV Adult, Chronic Dengue, Symp. DENV Pregnant, Symp. DENV Pediatric

Matrix Subtype :

Serum SST, Plasma EDTA K3

Available Clinical Data:

Diastolic Blood Pressure, Date of Birth, Test Manufacturer, Smoking History, Date of Draw, Systolic Blood Pressure, Ethnicity, Site Reported Dengue Testing Performed?, Body Mass Index, History of Diabetes?, If previously diagnosed with Dengue, which serotype?, Severe Plasma Leakage?, Height (cm), Date of Consent, Severe Organ Involvement?, Pregnant?, Time of Draw, Date of Diagnosis, Country of Origin, Has the subject been previously diagnosed with Dengue?, Date sample frozen at -20 C or colder, City of Origin, Is the subject still currently symptomatic for Dengue?, Has the subject presented with severe signs and symptoms for Dengue?, Gender, If pregnant, which trimester?, Date of site reported dengue testing, Fever Temperature (F), Concomitant Medications (if reported), Tropical Disease Signs and Symptoms, Weight, kg, Date of onset of first symptoms, Time Frozen at -20 C or colder, Is the subject currently on medications?

Available Tests:

Chikungunya Antibody, IgM, Trypanosoma cruzi, IgG, Chikungunya Antibody, IgG, West Nile Virus Antibody, IgG by ELISA, Serum, Abbott Anti-HCV, Abbott HIV Ag/AB Combo, Abbott HBsAg Qualitative, Dengue Virus (1-4) Subtype by PCR, AdviseDx SARS-CoV-2 IgM, Dengue Fever Virus Antibody, IgM, Architect SARS-CoV-2 IgG, Dengue Fever Virus Antibody, IgG, West Nile Virus Antibody, IgM by ELISA, Serum

Sample Subtype :

Dialysis

Matrix Subtype :

Plasma, Serum, Serum SST, Dialyzate Fluid, Urine, Plasma EDTA K3

Available Clinical Data:

Date of Draw, Days subject undergoes dialysis, Creatine, Time of Draw, How long (hours) is each Dialysis procedure?, Time of Death, Date of Death, Blood Counts, Date of first dialysis

Available Tests:

NT-Pro BNP, Parathyroid Hormone, Intact, Abbott Anti-HCV, Thyroxine, Free (Free T4), Thyroxine, Abbott HIV Ag/AB Combo, C-Reactive Protein, Abbott HBsAg Qualitative, Abbott Syphilis TP, Abbott Architect Procalcitonin, Triiodothyronine, Free (Free T3)

Sample Subtype :

EBV IgG, EBV IgG., EBV

Matrix Subtype :

Plasma, Serum, Plasma EDTA K2, Plasma EDTA K3

Available Clinical Data:

Reported Age, Date Treatment or Medication 1 Began, Date of Draw, Ethnicity, Date Treatment or Medication 2 Ended, Height (cm), Current Medications or Treatments 2, Time of Draw, Storage Start Date, Country of Origin, Date Treatment or Medication 1 Ended, Gender, Concomitant Medications (if reported), Start time of blood processing, Current Medications or Treatments 1, Storage Start Time, Weight, kg, Date Treatment or Medication 2 Began

Available Tests:

Epstein-Barr Virus Ab to Early D Antigen, IgG, EBV by Quantitative PCR, Abbott Anti-HCV, Epstein-Barr virus Ab to Viral Capsid Antigen, IgM, CMV IgG, Abbott HIV Ag/AB Combo, Abbott HBsAg Qualitative, EBV VCA IgG, EBV by Qualitative PCR, Epstein-Barr Virus Ab to Viral Capsid Antigen, IgG, Epstein-Barr Virus Ab to Nuclear antigen, Igg

Sample Subtype :

End-stage Cirrhosis

Matrix Subtype :

Serum SST, Plasma EDTA K3

Available Clinical Data:

Date of Birth, Reported Age, Fibrosis Score (Choose One), Date of Draw, Ethnicity, Periportal Necroinflammatory Score (Choose one), Test Date (site reported results), Date of Consent, Autoimmune Disease Signs and Symptoms, Abbott Architect Anti HCV Result, Pre-Existing Medical Conditions, Time of Draw, Date of Diagnosis, Portal Inflammation Score (Choose one), Country of Origin, Date sample frozen at -20 C or colder, City of Origin, Is the most recent liver biopsy result available?, Gender, Liver Biopsy Date Tested:, If pregnant, which trimester?, Scoring System: Focal (Spotty) Lobular Necrosis and Hepatocellular Apoptosis Score (Choose one), Did the subject receive a covid-19 vaccination, Concomitant Medications (if reported), Scoring System: Bridging and Confluent Necrosis Score (Choose One), Time Frozen at -20 C or colder, Site reported laboratory results, Sample Storage Temperature

Available Tests:

Albumin, Serum or Plasma, Carbon Dioxide, Serum or Plasma, Rheumatoid Factor, Creatinine, Serum or Plasma, Protein Total, Serum/Plasma, Total Protein, Potassium, Serum or Plasma, Anion Gap, Glucose, Serum or Plasma, Total Bilirubin, Aspartate Aminotransferase, Chloride, Serum or Plasma, Alanine Aminotransferase, Sodium, Serum or Plasma, Abbott Anti-HCV, Anti-Nuclear Antibodies (ANA), IgG by ELISA, Abbott HIV Ag/AB Combo, AST, Abbott HBsAg Qualitative, Alkaline Phosphatase, ALT, Abbott Syphilis TP, Calcium, Serum or Plasma, Urea Nitrogen, Serum or Plasma, ANA, IgG by IFA, Bilirubin, Total, Serum or Plasma, Cyclic Citrullinated Peptide (CCP) Antibody, IgG

Sample Subtype :

EBV IgG, EBV VCA IGM

Matrix Subtype :

Plasma

Available Tests:

Epstein-Barr Virus Ab to Early D Antigen, IgG, Epstein-Barr virus Ab to Viral Capsid Antigen, IgM, Epstein-Barr Virus Ab to Viral Capsid Antigen, IgG, Epstein-Barr Virus Ab to Nuclear antigen, Igg

Sample Subtype :

Febrile, Febrile Pediatric

Matrix Subtype :

Serum, Serum SST, Plasma EDTA K3

Sample Subtype :

Ferritin

Matrix Subtype :

Serum

Available Tests:

Ferritin

Sample Subtype :

B12

Matrix Subtype :

Plasma Na Heparin, Serum, Plasma Lithium Heparin

Available Tests:

B12, ALT, Vitamin B12

Sample Subtype :

Gentamicin

Matrix Subtype :

Serum

Sample Subtype :

Glucose

Matrix Subtype :

Serum

Sample Subtype :

Graves' Disease

Matrix Subtype :

Serum SST

Available Clinical Data:

Date of Birth, Reported Age, Date of Draw, Ethnicity, Test Date (site reported results), Date of Consent, Autoimmune Disease Signs and Symptoms, Pre-Existing Medical Conditions, Time of Draw, Date of Diagnosis, Country of Origin, Date sample frozen at -20 C or colder, City of Origin, Gender, If pregnant, which trimester?, Did the subject receive a covid-19 vaccination, Concomitant Medications (if reported), Time Frozen at -20 C or colder, Site reported laboratory results

Available Tests:

Albumin, Serum or Plasma, Carbon Dioxide, Serum or Plasma, Rheumatoid Factor, Creatinine, Serum or Plasma, Protein Total, Serum/Plasma, Potassium, Serum or Plasma, Anion Gap, Glucose, Serum or Plasma, Aspartate Aminotransferase, Chloride, Serum or Plasma, Alanine Aminotransferase, Sodium, Serum or Plasma, Anti-Nuclear Antibodies (ANA), IgG by ELISA, Alkaline Phosphatase, Calcium, Serum or Plasma, Urea Nitrogen, Serum or Plasma, ANA, IgG by IFA, Bilirubin, Total, Serum or Plasma, Cyclic Citrullinated Peptide (CCP) Antibody, IgG

Sample Subtype :

HAVPL, Acute HAV, HAV

Matrix Subtype :

Saliva, WB PAXgene RNA, Plasma, Serum, Plasma EDTA K2, Whole Blood, Urine, Plasma Na Citrate, Plasma EDTA K3, Plasma PPT EDTA K2

Available Clinical Data:

Donor HCV Status, Date of Birth, Reported Age, Donor HBV Status, Date of Draw, Time of Centrifugation, Ethnicity, Does the patient have diagnostic testing?, Subject is 18 years of age or older at the time of enrollment and blood draw, Height (cm), Test Date (site reported results), Donor HIV Status, Date of Consent, Signs and Symptoms (Hepatitis A), Tropical Disease Other Signs and Symptoms, Pre-Existing Medical Conditions, Date of Diagnosis, Time of Draw, Clinical Observations, Storage Start Date, Country of Origin, City of Origin, Suspected Tropical Disease, Signs and Symptoms at the Time of Draw., Alcohol use?, Gender, Subject receiving treatment, Concomitant Medications (if reported), Start time of blood processing, Storage Start Time, comorbidities?, Tropical Disease Signs and Symptoms, Weight, kg, Date of onset of first symptoms, Patient Has Documentation For Yellow Fever Vaccination, Time Frozen at -20 C or colder, Site reported laboratory results

Available Tests:

Genetic Systems HBsAg EIA 3.0, HAV RT-PCR, UltraQual 1000 2x, Architect Anti-HAV IgG, EBV by Qualitative PCR, Architect Anti-HAV IgM, HAV RT-PCR (AmpliSens PCR Kit), Syphilis MHA-TP, COBAS AmpliPrep/COBAS TaqMan HIV-1 Test v2.0, WNV-PCR: (Roche WNV-PCR)

Sample Subtype :

HBcAb

Matrix Subtype :

Serum

Sample Subtype :

HBeAG

Matrix Subtype :

Serum

Sample Subtype :

HBcIgM, HBcAb, Acute HBV, HBV, HBeAb, HBsAg

Matrix Subtype :

Serum Non-SST, Plasma, Serum, Plasma EDTA K2, Serum SST, Plasma CPD, Plasma Na Citrate, Plasma EDTA K3, Human Cord Serum, Plasma PPT EDTA K2

Available Clinical Data:

HBV Genotype test performed?:, If on medications, for how long? (days), Date of Birth, Presence of metastasis (M), Extent of spread to the lymph nodes (N), Reported Age, If Yes, How long? years months, Description of Diagnosis, Date of Draw, If yes, result: (HBV Genotype test performed), Ethnicity, Extent of the tumor (T), Signs and Symptoms (Hepatitis B), Subject is 18 years of age or older at the time of enrollment and blood draw, Tumour Location, Date of Consent, Date tested (Liver biopsy), If yes, result: (Anti H Be test performed), Stage of Cancer, Date of Diagnosis, Time of Draw, If yes, date performed ( HBV Genotype test performed), Tumor Size (cm), Current HBV Medications (please check all types that apply):, Country of Origin, City of Origin, If yes, stage of biopsy (Biopsy performed), Biopsy performed?, Histologic Type, If yes, date performed (Biopsy performed), Date of Diagnosis of Hepatitis B Infection, Method of Verification, Gender, Clinical state of Hepatitis B infection, Infection Status

Available Tests:

Genetic Systems HBsAg EIA 3.0, Quest HBV_Genotype, Hepatitis Be Virus Antigen, n/a, COBAS Ampliprep/TaqMan 48 HBV, v2.0, Abbott HBc IgM, DiaSorin HBeAg, Immunoglobulin G, Hepatitis B Virus Core Antibody, IgM, HBV Precore Mutations, HBV Mutations: Other, Liaison CMV IgM, COBAS AmpliPrep/COBAS HCV Test v2.0. (Roche Molecular Systems Inc), Hepatitis B Core Antibodies, Total, HBV Precore (TAG) Mutations, Abbott Anti-HCV, Abbott HB Core, Liaison CMV IgG, HBV BCP Mutations, Abbott HIV Ag/AB Combo, COBAS AmpliPrep HIV-1 Test, Abbott HBsAg Qualitative, Versant HBV bDNA 3.0, Hepatitis Be Virus Antibody, Abbott Syphilis TP, Hepatitis B Virus Genotype by Sequencing, PRISM HBsAg, Quest Diagnostics HBV Genotyping LDT, DiaSorin Anti-HBe, COBAS AmpliPrep/COBAS TAQMAN HBV Test V2.0 (Roche Molecular Systems Inc.), HBV Polymerase Mutations, TRUGENE HBV genotyping assay_Siemens Medical Solutions Diagnostics, Hepatitis B Virus Surface Antibody, COBAS AmpliPrep/COBAS TaqMan HIV-1 Test v2.0, Abbott Anti-HBs (AUSAB)

Sample Subtype :

HCV GT 5, HCV GT 1B, HCV GT 2B, HCV GT 4A, HCV GT 3, HCV Ag, HCV GT 4, HCV GT 4C, HCV GT 3A, HCV IgM, Acute HCV, HCV GT 1A, HCV GT 6, HCV GT 4E, HCV, HCV GT 3B

Matrix Subtype :

Plasma ACD-A, Plasma, Serum, Plasma CPDA, Serum SST, Plasma CPD, Plasma EDTA K3

Available Clinical Data:

Date of Birth, Reported Age, Date Treatment or Medication 1 Began, Test Manufacturer, HCV Genotype / Subtype Test performed?, Date of Draw, Time of Centrifugation, Ethnicity, Sample Hemolysis Level (Qualtex Color Comparator), Current HCV Medications (Select all that apply), HCV Viral Load Performed (within last 90 days), Date of Consent, Date tested (Liver biopsy), If yes, date performed? (HCV Genotype), Time of Draw, Date of Diagnosis, Clinical State of Hepatitis C Infection, Country of Origin, Genotype and Subtype (HCV Genotype), Date sample frozen at -20 C or colder, City of Origin, If yes, stage of biopsy (Biopsy performed), Biopsy performed?, Gender, Fibrosis Score, If pregnant, which trimester?, Concomitant Medications (if reported), Current Medications or Treatments 1, Date of onset of first symptoms, Time Frozen at -20 C or colder

Available Tests:

INNO-LiPA HCV Genotype, Hepatitis Be Virus Antigen, Anti-HCV IgG NS5 (Vitro-Test_Ukraine), n/a, COBAS Ampliprep/TaqMan 48 HBV, v2.0, Total Protein, Hepatitis C IgM (Vitro-Test_Ukraine), Ortho HCV Version 3.0 ELISA Test System, Total Bilirubin, Immunoglobulin G, Hepatitis C Viral RNA LiPA, Hepatitis B Virus Core Antibody, IgM, Liaison CMV IgM, COBAS AmpliPrep/COBAS HCV Test v2.0. (Roche Molecular Systems Inc), Hepatitis B Core Antibodies, Total, Abbott Anti-HCV, Abbott HB Core, Bayer VERSANT HCV RNA 3.0, Liaison CMV IgG, COBAS AmpliPrep COBAS TaqMan HCV Test v2.0, Abbott HIV Ag/AB Combo, COBAS AmpliPrep HIV-1 Test, Abbott HBsAg Qualitative, Hep C Virus Genotyping, Versant HCV RNA ASSAY (bDNA) 3.0, Anti-HCV IgG NS3 (Vitro-Test_Ukraine), Anti-HCV IgG cor (Vitro-Test_Ukraine), Hepatitis Be Virus Antibody, Procleix Ultrio Plus, COBAS Ampliprep/TaqMan 48 HIV-1, v2.0, PRISM HBsAg, Anti-HCV IgG NS4 (Vitro-Test_Ukraine), Quest Diagnostics HBV Genotyping LDT, COBAS Ampliprep/TaqMan48 HCV, v2.0, COBAS AmpliPrep/COBAS TAQMAN HBV Test V2.0 (Roche Molecular Systems Inc.), eSensor HCVg Direct test, Hepatitis B Virus Surface Antibody, COBAS AmpliPrep/COBAS TaqMan HIV-1 Test v2.0

Sample Subtype :

IgM, Total Antibodies, HDV

Matrix Subtype :

Plasma, Serum

Available Clinical Data:

Reported Age, Date of Draw, Ethnicity, Gender

Available Tests:

Hepatitis Delta Virus Antibody, Hepatitis D Virus PCR AmpliSens, Hepatitis D Total Antibodies, Hepatitis D, IgM

Sample Subtype :

Helicobacter pylori

Matrix Subtype :

Plasma, Plasma EDTA K2

Available Clinical Data:

Identity of Bacterial Infection

Available Tests:

H.pylori

Sample Subtype :

HEV, HEV IgM, HEVAb

Matrix Subtype :

Plasma, Serum

Available Tests:

Hepatitis E Virus (HEV) Antibody, IgG, Hepatitis E Virus (HEV) IgM, Hepatitis E Virus (HEV) Antibody, IgM

Sample Subtype :

HGV

Matrix Subtype :

Serum

Available Tests:

Hepatitis G Virus PCR

Sample Subtype :

HR HIV, HIV-2, Adult High Risk, HR HCV, HR HIV Preg, HBV, High Risk, High Risk HIV-2, HCV

Matrix Subtype :

Plasma, Serum, Plasma EDTA K2, Plasma EDTA K3

Available Clinical Data:

Date of Birth, HCV Risk Factors, Fibrosis Score (Choose One), Date of Draw, Time of Centrifugation, Ethnicity, Periportal Necroinflammatory Score (Choose one), Sample Hemolysis Level (Qualtex Color Comparator), Date of Consent, Time of Draw, Portal Inflammation Score (Choose one), Country of Origin, Date sample frozen at -20 C or colder, City of Origin, Is the most recent liver biopsy result available?, Gender, If pregnant, which trimester?, Scoring System: Focal (Spotty) Lobular Necrosis and Hepatocellular Apoptosis Score (Choose one), Concomitant Medications (if reported), Scoring System: Bridging and Confluent Necrosis Score (Choose One), Subject is at increased risk of HIV Infection. See below Table 1. Check one or more of the following risk factors. Present documentation when applicable, Time Frozen at -20 C or colder, Sample Storage Temperature

Available Tests:

Ferritin, Rheumatoid Factor, Bordetella pertussis Antibody, IgG by ELISA, Hepatitis Be Virus Antigen, CMV Antibody IgG, Total Protein, Bio-Rad BioPlex 2200 HIV Ag-Ab, Bio-Rad Geenius HIV 1/2 Supplemental Assay, TSH, Total Bilirubin, Influenza A Virus Antibody IgM, Mycoplasma Pneumoniae Antibody IgM, Hepatitis B Virus Core Antibody, IgM, NT-Pro BNP, Influenza B Virus Antibody IgM, Insulin-Like Growth Factor (IGF-1), FSH, Hepatitis B Core Antibodies, Total, Zeptometrix HIV-1 p24 Antigen, Abbott Anti-HCV, Hepatitis A Virus Antibodies (Total), Mycoplasma Pneumoniae Antibody IgG, Anti-Nuclear Antibodies (ANA), IgG by ELISA, Liaison CMV IgG, Human Chorionic Gonadotropin (hCG), HIV-1 Viral Load, Luteinizing Hormone (LH), Abbott HIV Ag/AB Combo, LIAISON Mumps IgG, AST, Free T3, Abbott HBsAg Qualitative, Alkaline Phosphatase, ALT, Hepatitis Be Virus Antibody, Abbott Syphilis TP, Prostatic Specific Antigen, Total, Influenza A Virus Antibody IgG, PSA (Prostatic Specific Antigen), Influenza B Virus Antibody IgG, Direct Bilirubin, Epstein-Barr Virus Ab to Viral Capsid Antigen, IgG, Varicella-Zoster Virus Antibody, IgG, Progesterone II Gen, hGH, LIAISON Measles IgG, CMV Antibody IgM, Toxoplasma gondii Antibody, IgG, LIAISON Rubella IgG, Prolactin, Testosterone, Free T4, Free PSA (Prostatic Specific Antigen), Cyclic Citrullinated Peptide (CCP) Antibody, IgG, Hepatitis B Virus Surface Antibody

Sample Subtype :

HIV-G, HIV-O, HIV-2, HIV-1, HIV G/CRF 14, HIV, High Risk HIV-2, HIV-0

Matrix Subtype :

Serum Non-SST, WB EDTA K3, Plasma, Serum, WB EDTA K2, Plasma EDTA K2, Plasma CPDA, DBS (Finger Prick), Serum SST, WB Na Heparin, WB Greiner PPT, Plasma CPD, WB Serum, DBS (Venous), Plasma Na Citrate, Plasma Lithium Heparin, Plasma EDTA K3, Human Cord Serum

Available Clinical Data:

Date of Birth, If no has the subject been on previous antiretroviral medication?, Total days with supplemental oxygen, Reported Age, If Yes, How long? years months, Date DBS finger prick frozen at -20 C or colder, Symptomology at the Time of Diagnosis, Test Manufacturer, Date of ICU Admission, Date of Draw, Time of Centrifugation, Current HIV Medications (please check all types that apply):, Did the subject receive supplemental oxygen?, Ethnicity, Did the Subject Receive Other Therapeutic Interventions?, Sample Hemolysis Level (Qualtex Color Comparator), Date of DBS venous, Combination HIV medicines, Date of HIV diagnosis, Subject is 18 years of age or older at the time of enrollment and blood draw, Height (cm), COVID-19 Molecular Test Manufacturer, Date of DBS finger prick, Blood Type, Was the subject admitted to the intensive care unit (ICU)?, Test Date (site reported results), Date of finger prick, Date of Consent, Fusion Inhibitors, Date of Discharge from ICU, Pre-Existing Medical Conditions, Time of Draw, In the 14 days prior to illness onset, did the subject have any of the following exposures?, Date of Diagnosis, If Yes, How long? months years, Integrase Inhibitors, Time of DBS finger prick, Pharmacokinetic Enhancers, Previous HIV Medications, Other (Medications), Country of Origin, Date sample frozen at -20 C or colder, City of Origin, Did the subject receive Mechanical Ventilation (MV) / Intubation?, Signs and Symptoms at the Time of Draw., HIV Risk Factors, Alcohol use?, Time of DBS venous, Gender, Was the subject hospitalized?, Time of finger prick, If pregnant, which trimester?, Subject receiving treatment, Date of hospitalization, Non-nucleoside Reverse Transcriptase Inhibitors (NRTIs), Fever Temperature (F), Concomitant Medications (if reported), Protease Inhibitors (PIs), Is the subject a healthcare worker?, comorbidities?, Nucleoside Reverse Transcriptase Inhibitors (NRTIs), Time DBS finger prick frozen at -20 C or colder, Weight, kg, Date of onset of first symptoms, Subject is at increased risk of HIV Infection. See below Table 1. Check one or more of the following risk factors. Present documentation when applicable, Time DBS venous frozen at -20 C or colder, Date DBS venous frozen at -20 C or colder, Time Frozen at -20 C or colder, Date of discharge from hospital?, Day(s) subject received mechanical ventilation (MV) / Intubation, Site reported laboratory results

Available Tests:

Genetic Systems HBsAg EIA 3.0, Versant HIV-1 RNA 3.0 (bDNA), n/a, Total Protein, Bio-Rad GEENIUS TEMPORARY CODE, HIV-2 Qual NAT, Bio-Rad BioPlex 2200 HIV Ag-Ab, Bio-Rad Geenius HIV 1/2 Supplemental Assay, Total Bilirubin, COBAS AmpliPrep COBAS TaqMan HIV-1 Test_Roche Molecular Systems, Immunoglobulin G, Beta-hCG, Serum Qualitative, Liaison CMV IgM, COBAS AmpliPrep/COBAS HCV Test v2.0. (Roche Molecular Systems Inc), Zeptometrix HIV-1 p24 Antigen, InBios WNV IgM, Abbott Anti-HCV, Abbott HB Core, HBsAg, Liaison CMV IgG, HIV-1 Viral Load, Cobas TaqScreen West Nile Virus, HIV-2 RNA PCR NAT, Abbott HIV Ag/AB Combo, LIAISON Mumps IgG, COBAS AmpliPrep HIV-1 Test, Abbott Real Time HIV-1, Abbott HBsAg Qualitative, InBios WNV IgG, Abbott Syphilis TP, HIV-1 by Quantitative PCR, Bio-Rad Genie III HIV-1/HIV-2, Epstein-Barr Virus Ab to Viral Capsid Antigen, IgG, Varicella-Zoster Virus Antibody, IgG, COBAS Ampliprep/TaqMan 48 HIV-1, v2.0, PRISM HBsAg, LIAISON Measles IgG, HIV-2 Quant NAT, HIV-2 SuperCycle Assay, LIAISON Rubella IgG, COBAS AmpliPrep/COBAS TAQMAN HBV Test V2.0 (Roche Molecular Systems Inc.), VelaDX Sentosa SQ HIV-1 Genotyping Assay, HIV-2 RNA Viral Load, COBAS AmpliPrep/COBAS TaqMan HIV-1 Test v2.0, WNV-PCR: (Roche WNV-PCR), Syphilis, Bio-Rad Genie II HIV-1/HIV-2

Sample Subtype :

Prolactin, BNP, Testosterone, AMH, Total T3, 25 OH Vitamin D, TSH, Free T4

Matrix Subtype :

Serum CAT, Saliva, Serum, Plasma EDTA K2, Plasma Lithium Heparin

Available Clinical Data:

Reported Age, Date of Draw, Ethnicity, Gender

Available Tests:

T3, TSH, Anti-Mullerian Hormone, T4, DiaSorin Zika IgM, Parathyroid Hormone, Intact, Thyroxine, Free (Free T4), T3-TOTAL, NT-proBNP, Direct Bilirubin, Vitamin D-25, Testosterone, Triiodothyronine, Free (Free T3), Prolactin

Sample Subtype :

Emergency Department, Clostridium difficile, Hospital ICU Sepsis, Elevated WBC, Hospital Patient

Matrix Subtype :

Plasma, Serum, WB EDTA K2, BAL, Urine, Plasma Lithium Heparin, CSF, Stool liquid, Sputum

Available Tests:

Triglycerides, Clostridium difficile, Alkaline Phosphate, CMV PCR, TSH, FilmArray RespComplete Panel, InBios Zika IgM Capture, Creatine, ALT, Abbott Architect Procalcitonin, BUN, Procalcitonin

Sample Subtype :

HSV-1, HSV-2, HSV

Matrix Subtype :

Plasma, Serum, Plasma EDTA K2, Aptima Vaginal Swab, Aptima Swabs

Available Clinical Data:

Reported Age, Donor Blood Type, Date of Draw, Ethnicity, Height (cm), Does the subject smoke?, Time of Draw, Storage Start Date, Country of Origin, Gender, Concomitant Medications (if reported), Start time of blood processing, Storage Start Time, Weight, kg

Available Tests:

HSV Type 1 and/or 2 Ab, IgM by ELISA, HSV Type 2 Glycoprotein G-Specific Ab, IgG by CIA, Herpes Simplex Virus (HSV-1/HSV-2) Subtype, HSV Type 1 Glycoprotein G-Specific Ab, IgG by CIA

Sample Subtype :

HTLV

Matrix Subtype :

Plasma, Serum SST, Plasma EDTA K3

Available Clinical Data:

Date of Birth, Subject has symptom / diagnosis of HAM / TSP, Signs and Symptoms (HAM / TSP), Date of Draw, Time of Centrifugation, Ethnicity, Signs and Symptoms (ATL), Subject is at increased risk for HTLV infection. Check one or more of the following risk factors., Stage of ATL, Date of Consent, Time of Draw, Country of Origin, City of Origin, Gender, Time Frozen at -20 C or colder

Available Tests:

Abbott Anti-HCV, HTLV II IFA_State of California Department of Public Health, Human T-Lymphotropic Virus (HTLV) Types I/II Antibodies by ELISA, HTLV I IFA_State of California Department of Public Health, Human T-Lymphotropic Virus Types I/II Antibodies, Western Blot, Abbott HIV Ag/AB Combo, Abbott HBsAg Qualitative, HTLV I/II EIA_State of California Department of Public Health, Abbott Syphilis TP

Sample Subtype :

Hyperglobulinemia

Matrix Subtype :

Plasma EDTA K3

Available Tests:

Hyperglobulinemia IgM, Hyperglobulinemia IgG

Sample Subtype :

IgA, IgE

Matrix Subtype :

Serum

Available Tests:

Total Immunoglobulin A, Atellica total Immunoglobulin E, Total Immunoglobulin E

Sample Subtype :

Increased Risk HIV-2, Increased Risk HCV, Inc. Risk HCV Ped., Increased Risk HIV-1

Matrix Subtype :

Serum Non-SST, Serum, Serum SST, Plasma EDTA K3

Available Clinical Data:

Date of Birth, HCV Risk Factors, Ethnicity (hispanic specific), Date of Draw, Time of Centrifugation, Ethnicity, Sample Hemolysis Level (Qualtex Color Comparator), Subject is 18 years of age or older at the time of enrollment and blood draw, Date of Consent, Time of Draw, Country of Origin, Date sample frozen at -20 C or colder, City of Origin, Subject is not at increased risk for HIV-1 infection., Gender, If pregnant, which trimester?, Subject is at increased risk of HIV Infection. See below Table 1. Check one or more of the following risk factors. Present documentation when applicable, Time Frozen at -20 C or colder

Available Tests:

Ferritin, Bordetella pertussis Antibody, IgG by ELISA, Hepatitis Be Virus Antigen, CMV Antibody IgG, Bio-Rad Geenius HIV 1/2 Supplemental Assay, TSH, Total Bilirubin, Influenza A Virus Antibody IgM, Mycoplasma Pneumoniae Antibody IgM, Hepatitis B Virus Core Antibody, IgM, Influenza B Virus Antibody IgM, Insulin-Like Growth Factor (IGF-1), Liaison CMV IgM, FSH, Hepatitis B Core Antibodies, Total, Zeptometrix HIV-1 p24 Antigen, Abbott Anti-HCV, Hepatitis A Virus Antibodies (Total), Mycoplasma Pneumoniae Antibody IgG, Liaison CMV IgG, Human Chorionic Gonadotropin (hCG), Luteinizing Hormone (LH), Abbott HIV Ag/AB Combo, LIAISON Mumps IgG, AST, Free T3, Abbott HBsAg Qualitative, Alkaline Phosphatase, ALT, Hepatitis Be Virus Antibody, Abbott Syphilis TP, Prostatic Specific Antigen, Total, Influenza A Virus Antibody IgG, PSA (Prostatic Specific Antigen), Influenza B Virus Antibody IgG, Direct Bilirubin, Progesterone II Gen, LIAISON H. pylori IgG, hGH, CMV Antibody IgM, Toxoplasma gondii Antibody, IgG, LIAISON Rubella IgG, Prolactin, Testosterone, Free T4, Free PSA (Prostatic Specific Antigen), Hepatitis B Virus Surface Antibody

Sample Subtype :

Increased Risk HAV

Matrix Subtype :

Serum SST, Plasma EDTA K3

Available Clinical Data:

Date of Birth, Date of Draw, Ethnicity, Country of Origin, Gender, Subject is at increased risk of Hepatitis A. See below Table 1. Check one or more of the following risk factors. Present documentation when applicable:

Available Tests:

Bordetella pertussis Antibody, IgG by ELISA, CMV Antibody IgG, Influenza A Virus Antibody IgM, Mycoplasma Pneumoniae Antibody IgM, Influenza B Virus Antibody IgM, Hepatitis A Virus Antibodies (Total), Mycoplasma Pneumoniae Antibody IgG, Influenza A Virus Antibody IgG, Influenza B Virus Antibody IgG, Architect Anti-HAV IgM, CMV Antibody IgM, Toxoplasma gondii Antibody, IgG

Sample Subtype :

Flu Vaccine, Influenza

Matrix Subtype :

WB EDTA K3, Serum, Whole Blood, Serum SST, Nasopharyngeal swabs, VTM, Nasal Swab, Plasma EDTA K3

Available Clinical Data:

Date of Birth, COVID-19 Vaccination Date, First Dose, Reported Age, Change in Concomitant Medications?, COVID-19 Vaccination Date, Second Dose, Date of Draw, Ethnicity, Vaccine manufacturer, Test Date (site reported results), Vaccine Name, Date of Consent, Pre-Existing Medical Conditions, Date of Diagnosis, Time of Draw, In the 14 days prior to illness onset, did the subject have any of the following exposures?, Clinical Observations, Did the subject receive a flu vaccine for this season?, Country of Origin, Date sample frozen at -20 C or colder, City of Origin, Signs and Symptoms at the Time of Draw., Was the subject previously diagnosed with COVID-19?, Was the subject diagnosed with COVID-19 since the last visit?, Gender, If pregnant, which trimester?, Fever Temperature (F), Did the subject receive a covid-19 vaccination, Concomitant Medications (if reported), Date of Vaccine Administration, Date of onset of first symptoms, Time Frozen at -20 C or colder, Change in underlying medical conditions and/or risk behavior?, Site reported laboratory results, History of Flu Vaccine Administration

Available Tests:

Influenza A/B FIA, Bordetella pertussis Antibody, IgG by ELISA, PolioVirus Antibody Type 3, Coxsackie B Virus Antibody Type 3, Influenza A Virus Antibody IgM, Coxsackie B Virus Antibody Type 6, Mycoplasma Pneumoniae Antibody IgM, Echovirus Antibody Type 7, Adenovirus Antibody, Serum, Influenza B Virus Antibody IgM, Echovirus Antibody Type 11, Liaison CMV IgM, Abbott Anti-HCV, Echovirus Antibody Type 6, Echovirus Antibody Type 30, Mycoplasma Pneumoniae Antibody IgG, Liaison CMV IgG, Abbott HIV Ag/AB Combo, Abbott HBsAg Qualitative, Coxsackie A9 Virus Antibodies, Abbott Syphilis TP, Influenza A Virus Antibody IgG, Influenza B Virus Antibody IgG, Coxsackie B Virus Antibody Type 5, FilmArray Respiratory Panel 2.1, Coxsackie B Virus Antibody Type 1, PolioVirus Antibody Type 1, Echovirus Antibody Type 9, Coxsackie B Virus Antibody Type 2, Coxsackie B Virus Antibody Type 4, Haemophilus influenzae b Antibody, IgG

Sample Subtype :

INR

Matrix Subtype :

Plasma, Serum

Available Clinical Data:

Donor Blood Type, Current Medications or Treatments 1

Available Tests:

International Normalized Ratio

Sample Subtype :

Insulin

Matrix Subtype :

Serum

Sample Subtype :

Lipemia

Matrix Subtype :

Plasma, Serum

Available Clinical Data:

Date of Birth, Lipemia (laboratory evidence), Reported Age, Elevated albumin (Alb) (laboratory evidence), Date of Draw, Ethnicity, Subject is 18 years of age or older at the time of enrollment and blood draw, Alcoholic cirrhosis (clinical diagnosis and/or laboratory evidence), Date of Consent, Time of Draw, Date of Diagnosis, Gastroenterology Condition, Country of Origin, Elevated alanine amino transferase (ALT) (laboratory evidence), City of Origin, Gender, Subject receiving treatment, Current Medications or Treatments 1, Medication Start Date, Date of onset of first symptoms

Available Tests:

Triglycerides, Rheumatoid Factor, Hepatitis Be Virus Antigen, Total Protein, Total Bilirubin, Cortisol, Immunoglobulin G, Hepatitis B Virus Core Antibody, IgM, NT-Pro BNP, Hepatitis B Core Antibodies, Total, Abbott Anti-HCV, LDL, Tissue Transglutaminase Antibody, IgG, Anti-Nuclear Antibodies (ANA), IgG by ELISA, Abbott HIV Ag/AB Combo, C-Reactive Protein, AST, Abbott HBsAg Qualitative, HDL, ALT, Hepatitis Be Virus Antibody, Cholesterol, Abbott Syphilis TP, Abbott Architect Procalcitonin, Immunoglobulin M, ANA, IgG by IFA, Immunoglobulin A, Tissue Transglutaminase (tTG) Antibody, IgA, Hepatitis B Virus Surface Antibody

Sample Subtype :

IPTH

Matrix Subtype :

Plasma, Serum

Available Tests:

TSH, iPTH

Sample Subtype :

Leishmaniasis

Matrix Subtype :

Plasma, Serum, Whole Blood, Urine, Plasma EDTA K3

Available Clinical Data:

Positive Leishmaniasis Biopsy?, Signs and Symptoms (Leishmaniasis), Date of onset of first symptoms, Leishmaniasis Infection Type

Available Tests:

Kalazar Detect Rapid Test for Visceral Leishmaniasis, Abbott Anti-HCV, InBios Zika IgM Capture, DiaPro Zika Virus IgG, InBios Anti-Dengue IgM, InBios Anti-Dengue IgG, DiaPro Anti-Chikungunya IgG, Abbott HIV Ag/AB Combo, Abbott HBsAg Qualitative, DiaPro Anti-Chikungunya IgM, Aptima Zika Virus Assay - Plasma

Sample Subtype :

ThinPrep Liquid

Matrix Subtype :

ThinPrep NILM

Sample Subtype :

Low Risk HIV, LR HIV

Matrix Subtype :

Serum, Serum SST, Plasma EDTA K3

Sample Subtype :

Lyme

Matrix Subtype :

WB EDTA K3, WB PAXgene RNA, Plasma, Serum, Whole Blood, Plasma EDTA K3

Available Clinical Data:

Date of Birth, Reported Age, Date Treatment or Medication 1 Began, Visit Number, Date of Draw, Time of Centrifugation, Ethnicity, Date Treatment or Medication 3 Ended, Date Treatment or Medication 2 Ended, Subject is 18 years of age or older at the time of enrollment and blood draw, Height (cm), Date of Tick Bite, Date of Consent, Current Medications or Treatments 2, Time of Draw, Date of Diagnosis, If yes, select confirmatory lab results, Treatment History, Clinical Observations, Current Medications or Treatments 3, Storage Start Date, Specify Tick-Borne illness, Tick Exposure Site, Country of Origin, Confirmatory lab results (Tick Born), Signs and Symptoms at the Time of Draw., Date Treatment or Medication 1 Ended, Where was the patient exposed?, Gender, Location on body of tick exposure, If pregnant, which trimester?, Concomitant Medications (if reported), Start time of blood processing, Current Medications or Treatments 1, Storage Start Time, Weight, kg, Date of onset of first symptoms, Date Treatment or Medication 3 Began, Time Frozen at -20 C or colder, Date Treatment or Medication 2 Began, Signs and Symptoms (Tick Born Disease)

Available Tests:

Borrelia Species by PCR (Lyme Disease), Total Protein, Bio-Rad BioPlex 2200 HIV Ag-Ab, Bio-Rad Geenius HIV 1/2 Supplemental Assay, Total Bilirubin, Ehrlichia chaffeensis Ab, IgG by IFA, Ehrlichia chaffeensis Ab, IgM by IFA, Lyme IgG-IgM, Abbott Anti-HCV, HIV-1 Viral Load, DiaSorin Lyme, Anaplasma phagocytophilum (HGA) Ab, IgM, Abbott HIV Ag/AB Combo, Abbott HBsAg Qualitative, Borrelia burgdorferi Antibodies, IgG by Immunoblot, Borrelia burgdorferi Ab, Total ELISA, Babesia microti Ab IgG by IFA, Immunetics C6 B.burgdorferi Lyme, Rickettsia typhi (Typhus Fever) Antibody, IgM by IFA, Babesia microfi Ab IgM by IFA, Borrelia burgdorferi Antibodies, IgM by Immunoblot, Anaplasma phagocytophilum (HGA) Antibody, IgG, Rickettsia typhi (Typhus Fever) Antibody, IgG by IFA

Sample Subtype :

Measles

Matrix Subtype :

Serum, Serum SST, Plasma EDTA K3, Human Cord Serum

Available Clinical Data:

Date of Birth, Date of Draw, Time of Centrifugation, Ethnicity, Date of Consent, Time of Draw, Date of Diagnosis, Country of Origin, City of Origin, Signs and Symptoms (Measles), Gender, Site Reported Measles Test (IgM by Flocculation), Date of onset of first symptoms, Time DBS venous frozen at -20 C or colder, Time Frozen at -20 C or colder

Available Tests:

BIO-RAD BIOPLEX Measles, Abbott Anti-HCV, Abbott HIV Ag/AB Combo, LIAISON Mumps IgG, Abbott HBsAg Qualitative, Measles (Rubeola) Antibody, IgM, LIAISON Measles IgG, Measles IgG

Sample Subtype :

Multiple Myeloma

Matrix Subtype :

Plasma

Sample Subtype :

Multiple Sclerosis

Matrix Subtype :

Plasma, Serum

Sample Subtype :

Mumps

Matrix Subtype :

Serum, Serum SST

Available Tests:

Abbott Anti-HCV, Abbott HIV Ag/AB Combo, LIAISON Mumps IgG, Abbott HBsAg Qualitative, Mumps IgG, Abbott Syphilis TP, LIAISON Measles IgG, LIAISON Rubella IgG

Sample Subtype :

Mycoplasma Pneumonia

Matrix Subtype :

Plasma

Sample Subtype :

NASH

Matrix Subtype :

Plasma EDTA K2, Serum SST, Plasma EDTA K3

Available Clinical Data:

Date of Birth, Ethnicity (hispanic specific), Reported Age, Date of Draw, Albumin, Ethnicity, Prothrombin Date Performed, Bilirubin, Subject is 18 years of age or older at the time of enrollment and blood draw, Albumin Test Range, Prothrombin Time, Date of Consent, Abbott Architect Anti HCV Result, Bilirubin test range, Time of Draw, Date of Fibrosis Score, Albumin Test Date, Date Bilirubin Test Performed, Country of Origin, Date sample frozen at -20 C or colder, City of Origin, Is the most recent liver biopsy result available?, If yes, stage of biopsy (Biopsy performed), If yes, date performed (Biopsy performed), Gender, Fibrosis Score, State of Origin, Time Frozen at -20 C or colder, Sample Storage Temperature

Available Tests:

AST, ALT, Architect SARS-CoV-2 IgG

Sample Subtype :

Adult Male, Normal Spleen, Challenged HIV Neg., HAV Vaccination, Normal Healthy

Matrix Subtype :

Serum Non-SST, Saliva, WB EDTA K3, WB PAXgene RNA, Plasma, Serum, Norgen Saliva RNA, WB EDTA K2, Plasma EDTA K2, Plasma CPDA-1, Whole Blood, DBS (Finger Prick), WB ACD-A, Saline OPS, Throat Swab, WB Na Citrate, Serum SST, Nasopharyngeal swabs, Dry NP Swab, Buccal Swab, Fresh Tissue, Oropharyngeal Swab, Spectrum DNA Saliva, BAL, Plasma CPD, Urine, Nasal Swab, DBS (Venous), Plasma Na Citrate, Plasma Lithium Heparin, Plasma EDTA K3

Available Clinical Data:

Examination Procedure (Oncology), pangoLEARN version, Donor HCV Status, Date of Birth, Presence of metastasis (M), COVID-19 Vaccination Date, First Dose, Nucleotide Substitutions, Extent of spread to the lymph nodes (N), Reported Age, Date DBS finger prick frozen at -20 C or colder, SARS-CoV-2 PANGOLIN Lineage, Donor HBV Status, Date of Surgery, COVID-19 Vaccination Date, Second Dose, Test Manufacturer, Donor is healthy and no history of thyroid disease and has no treatment for thyroid disease., Smoking History, Date of Draw, Ethnicity, Extent of the tumor (T), Vaccine manufacturer, Surgical Procedure, Height (cm), Percent of Genome Coverage, Blood Type, SARS-CoV-2 Nextstrain Clade, Test Date (site reported results), Vaccine Name, Donor HIV Status, Does the subject smoke?, Tumour Location, Subject has symptoms of hypothyroid or thyroid disease, Date of Consent, Amino Acid Substitutions, Stage of Cancer, Pre-Existing Medical Conditions, Time of Draw, Time of DBS finger prick, Distant metastasis location, Examination Procedure Findings, Storage Start Date, Country of Origin, Date sample frozen at -20 C or colder, City of Origin, Drug use?, Diagnosis (Oncology), Histologic Type, Alcohol use?, Time of DBS venous, Sequencing reference genome (GenBank Accession), Gender, Grade of Cancer, Time of finger prick, Buccal Swab Collection Site, If pregnant, which trimester?, Date of Procedure, Nucleotide Deletions, Did the subject receive a covid-19 vaccination, Concomitant Medications (if reported), Start time of blood processing, Storage Start Time, Time DBS finger prick frozen at -20 C or colder, Weight, kg, Date of Vaccine Administration, Time DBS venous frozen at -20 C or colder, Date DBS venous frozen at -20 C or colder, Time Frozen at -20 C or colder, Site reported laboratory results

Available Tests:

Anti-T.cruzi, Hematocrit Count, Hepatitis Be Virus Antigen, CMV Antibody IgG, LIAISON XL SARS-CoV-2 S1/S2, Herpes Simplex Virus Type 1 and/or 2 Antibodies, IgG, Platelet Count (PLT), Liaison HSV-2 IgG, Alpha Fetoprotein, Serum (Tumor Marker), COVID-19 IgG, Qualitative by CIA, Anti-Mullerian Hormone, DiaSorin Zika IgM, Influenza A Virus Antibody IgM, DiaSorin HBeAg, WNV RNA, EuroImmun COVID-19 IgG, Hepatitis B Virus Core Antibody, IgM, Aptima Zika Virus Assay - Urine, Candida Antibody IgM, Influenza B Virus Antibody IgM, Hepatitis B Core Antibodies, Total, Toxoplasma gondii Ab, IgM, Abbott Anti-HCV, Abbott HB Core, Hepatitis A Virus Antibodies (Total), Liaison SARS-CoV-2 IgM, HBsAg, BioGX SARS-CoV-2, Epstein-Barr virus Ab to Viral Capsid Antigen, IgM, Liaison CMV IgG, EDI COVID-19 IgM, Abbott HIV Ag/AB Combo, Abbott HBsAg Qualitative, EuroImmun COVID-19 IgA, Hepatitis Be Virus Antibody, Abbott Syphilis TP, Influenza A Virus Antibody IgG, HIV 1/2 ab, Influenza B Virus Antibody IgG, Perkin Elmer SARS-CoV-2 SWAB, Epstein-Barr Virus Ab to Viral Capsid Antigen, IgG, Candida Antibody IgA, Zika Virus RNA, CMV Antibody IgM, Toxoplasma gondii Antibody, IgG, Creatinine, LIAISON Rubella IgG, Perkin Elmer SARS-CoV-2 SALIVA, DiaSorin Anti-HBe, Liaison HSV-1 IgG, AdviseDx SARS-CoV-2 IgM, Hepatitis B Core Ab, EDI COVID-19 IgG, Rubella Antibody, IgG, GLUCOSE, Architect SARS-CoV-2 IgG, BUN, Candida Antibody IgG, Hepatitis B Virus Surface Antibody, Syphilis, Abbott Anti-HBs (AUSAB)

Sample Subtype :

NT-proBNP

Matrix Subtype :

Serum

Available Clinical Data:

Reported Age, Date of Draw, Gender

Available Tests:

NT-proBNP

Sample Subtype :

Immunosuppressant

Matrix Subtype :

WB EDTA K3, Plasma EDTA K3

Available Clinical Data:

Date of Birth, Reported Age, Date of Transplant, Date of Draw, Time of Centrifugation, Ethnicity, Type of Transplant, Date of Consent, Time of Draw, Country of Origin, Date of Immunosuppressant Drug Administration / Treatment Start, Subject has undergone an organ transplant procedure., Gender, Subject is currently taking at least one of the following immunosuppressant drugs: Cyclosporine, Sirolimus, Tacrolimus, or Everolimus., Time Frozen at -20 C or colder, Immunosuppressant Drug

Available Tests:

Tacrolimus by Tandem Mass Spectrometry, Cyclosporine A by Tandem Mass Spectrometry, Sirolimus by Tandem Mass Spectrometry

Sample Subtype :

Osteoarthritis

Matrix Subtype :

Plasma, Serum

Sample Subtype :

PBC

Matrix Subtype :

Serum SST, Plasma EDTA K3

Available Clinical Data:

Date of Birth, Reported Age, Fibrosis Score (Choose One), Date of Draw, Ethnicity, Periportal Necroinflammatory Score (Choose one), Subject is 18 years of age or older at the time of enrollment and blood draw, Test Date (site reported results), Date of Consent, Autoimmune Disease Signs and Symptoms, Pre-Existing Medical Conditions, Time of Draw, Date of Diagnosis, Portal Inflammation Score (Choose one), Country of Origin, Date sample frozen at -20 C or colder, City of Origin, Is the most recent liver biopsy result available?, Gender, Liver Biopsy Date Tested:, If pregnant, which trimester?, Scoring System: Focal (Spotty) Lobular Necrosis and Hepatocellular Apoptosis Score (Choose one), Did the subject receive a covid-19 vaccination, Concomitant Medications (if reported), Current Medications or Treatments 1, Scoring System: Bridging and Confluent Necrosis Score (Choose One), Time Frozen at -20 C or colder, Site reported laboratory results, Sample Storage Temperature

Available Tests:

Albumin, Serum or Plasma, Carbon Dioxide, Serum or Plasma, Rheumatoid Factor, Creatinine, Serum or Plasma, Protein Total, Serum/Plasma, Potassium, Serum or Plasma, Anion Gap, Glucose, Serum or Plasma, Aspartate Aminotransferase, Chloride, Serum or Plasma, Alanine Aminotransferase, Sodium, Serum or Plasma, Anti-Nuclear Antibodies (ANA), IgG by ELISA, AST, Alkaline Phosphatase, ALT, Calcium, Serum or Plasma, Urea Nitrogen, Serum or Plasma, ANA, IgG by IFA, Bilirubin, Total, Serum or Plasma, Cyclic Citrullinated Peptide (CCP) Antibody, IgG

Sample Subtype :

Newborn, Pediatric, Tanner Stage 4, HIV Pediatric, Tanner Stage 1, Healthy Pediatric

Matrix Subtype :

Plasma, Serum, Plasma EDTA K2, Serum SST, Plasma EDTA K3

Available Clinical Data:

Date of Birth, Reported Age, Date of Draw, Time of Centrifugation, Ethnicity, Vaccine manufacturer, Vaccine Name, Date of Consent, Current Medications or Treatments 2, Time of Draw, Date of Diagnosis, Infant Age, Current Medications or Treatments 3, Country of Origin, City of Origin, Gender, If pregnant, which trimester?, Current Medications or Treatments 1, Date of Vaccine Administration, Time Frozen at -20 C or colder

Available Tests:

Triglycerides, Vitamin D-25-Hydroxy, Alkaline Phosphate, Bio-Rad Geenius HIV 1/2 Supplemental Assay, TSH, Abbott Anti-HCV, PROGESTERONE, T3-TOTAL, Lipase, Abbott HIV Ag/AB Combo, C-Reactive Protein, Free T3, AST, Abbott HBsAg Qualitative, EBV VCA IgG, Vitamin B12, Free T4, LDH, ESTRADIOL, GGTP

Sample Subtype :

Pregnancy, Healthy Pregnancy, HIV Pregnancy

Matrix Subtype :

Plasma, Serum, Plasma EDTA K2, Serum SST, Urine, Plasma EDTA K3

Available Clinical Data:

Diastolic Blood Pressure, Date of Birth, Reported Age, History of Chronic Hypertension?, Date of Draw, Systolic Blood Pressure, Time of Centrifugation, Ethnicity, Sample Hemolysis Level (Qualtex Color Comparator), History of Diabetes?, Date of Blood Pressure Measurement, Gender of the fetus, Date of HIV diagnosis, Height (cm), Test Date (site reported results), Months Pregnant?, Does the subject smoke?, Date of Consent, Parity, Time of Draw, Date of Diagnosis, Proteinuria result, History of Renal Disease, History of pre eclampsia in previous pregnancy, Country of Origin, Date sample frozen at -20 C or colder, City of Origin, Proteinuria Assessment Method, Delivery Outcome, Gender, If pregnant, which trimester?, Gestational Age (weeks), Time of Blood Pressure Measurement, Concomitant Medications (if reported), Weight, kg, Time Frozen at -20 C or colder, Site reported laboratory results, Gravidity

Available Tests:

Hematocrit Count, Ferritin, Bordetella pertussis Antibody, IgG by ELISA, Hepatitis Be Virus Antigen, CMV Antibody IgG, Total Protein, Herpes Simplex Virus Type 1 and/or 2 Antibodies, IgG, Platelet Count (PLT), Alpha Fetoprotein, Serum (Tumor Marker), Bio-Rad BioPlex 2200 HIV Ag-Ab, Bio-Rad Geenius HIV 1/2 Supplemental Assay, Liaision SARS-CoV-2 Ab, TSH, Total Bilirubin, Influenza A Virus Antibody IgM, Mycoplasma Pneumoniae Antibody IgM, Hepatitis B Virus Core Antibody, IgM, Aptima Zika Virus Assay - Urine, Beta-hCG, Serum Qualitative, Influenza B Virus Antibody IgM, Rubella Antibody, IgM, Insulin-Like Growth Factor (IGF-1), FSH, Hepatitis B Core Antibodies, Total, Toxoplasma gondii Ab, IgM, Abbott Anti-HCV, Uric Acid, Thyroxine, Free (Free T4), Mycoplasma Pneumoniae Antibody IgG, Liaison CMV IgG, Aptima Zika Virus Assay - Serum, Human Chorionic Gonadotropin (hCG), HIV-1 Viral Load, Luteinizing Hormone (LH), Abbott HIV Ag/AB Combo, LIAISON Mumps IgG, AST, Free T3, Abbott HBsAg Qualitative, Alkaline Phosphatase, ALT, Hepatitis Be Virus Antibody, Abbott Syphilis TP, Prostatic Specific Antigen, Total, Influenza A Virus Antibody IgG, Herpes Simplex Virus Type 1 and/or 2 Antibodies, IgM by ELISA, PSA (Prostatic Specific Antigen), Influenza B Virus Antibody IgG, Direct Bilirubin, Perkin Elmer SARS-CoV-2 SWAB, Epstein-Barr Virus Ab to Viral Capsid Antigen, IgG, Varicella-Zoster Virus Antibody, IgG, Beta-hCG, Serum Quantitative, Abbott Architect Procalcitonin, eGFR, Progesterone II Gen, hGH, LIAISON Measles IgG, CMV Antibody IgM, Toxoplasma gondii Antibody, IgG, Creatinine, LIAISON Rubella IgG, Prolactin, Testosterone, Triiodothyronine, Free (Free T3), Free T4, Free PSA (Prostatic Specific Antigen), Rubella Antibody, IgG, Architect SARS-CoV-2 IgG, Hepatitis B Virus Surface Antibody, Haemophilus influenzae b Antibody, IgG

Sample Subtype :

Procalcitonin

Matrix Subtype :

Serum

Available Tests:

Abbott Architect Procalcitonin, Procalcitonin

Sample Subtype :

Alpha-Feto Protein

Matrix Subtype :

Serum

Available Tests:

Alpha-Fetoprotein

Sample Subtype :

PSA

Matrix Subtype :

Serum

Available Tests:

PSA (Prostatic Specific Antigen), Cryptococcus Ag

Sample Subtype :

SARS-CoV-2, Symptomatic, Respiratory Infection

Matrix Subtype :

Liquid Amies, Serum Non-SST, Saliva, Multitrans medium, Plasma, Serum, Serum SST, Nasopharyngeal swabs, VTM, Saline, E-Swab, MSC Swab, UTM, Plasma EDTA K3, Aptima Swabs, VTM NPS, Sputum

Available Clinical Data:

pangoLEARN version, SARS-CoV-2 Variant Common Name, Date of Birth, Birth Year, COVID-19 Vaccination Date, First Dose, Nucleotide Substitutions, Reported Age, SARS-CoV-2 PANGOLIN Lineage, Symptomology at the Time of Diagnosis, Test Manufacturer, COVID-19 Vaccination Date, Second Dose, Subjects first COVID19 Molecular Test?, Date of Draw, Time of Centrifugation, Ethnicity, Does the subject reside in a congregate care setting?, Vaccine manufacturer, Height (cm), Location of the Worker's Health Center, COVID-19 Molecular Test Manufacturer, Percent of Genome Coverage, Did the subject Receive non-invasive Ventilation (NIV), Was the subject admitted to the intensive care unit (ICU)?, Test Date (site reported results), SARS-CoV-2 Nextstrain Clade, Date of Consent, Amino Acid Substitutions, Amino Acid Deletions, Oropharyngeal swab collection time, Pre-Existing Medical Conditions, Time of Draw, In the 14 days prior to illness onset, did the subject have any of the following exposures?, Infant Age, Did the subject receive a flu vaccine for this season?, Country of Origin, Saliva collection time, Date sample frozen at -20 C or colder, City of Origin, Is the subject symptomatic as defined by the CDC?, Did the subject receive Mechanical Ventilation (MV) / Intubation?, Signs and Symptoms at the Time of Draw., Was the subject previously diagnosed with COVID-19?, Sequencing reference genome (GenBank Accession), Gender, Was the subject hospitalized?, Did the subject have another diagnosis or etiology for their illness?, If pregnant, which trimester?, Did the subject have an abnormal EKG, Fever Temperature (F), Did the subject receive a covid-19 vaccination, Nucleotide Deletions, Concomitant Medications (if reported), Is the subject a healthcare worker?, Did the subject have an abnormal Chest X-ray, Nasopharyngeal swab collection time, Weight, kg, Date of onset of first symptoms, Time Frozen at -20 C or colder, Site reported laboratory results

Available Tests:

Hologic Panther SARS-CoV-2, NovaTek RSV IgG ELISA, LIAISON XL SARS-CoV-2 S1/S2, InBios SARS-CoV-2 IgG, Liaision SARS-CoV-2 Ab, Abbott Anti-HCV, GeneXpert SARS-CoV-2, Hologic Panther Fusion SARS-CoV-2, Liaison SARS-CoV-2 IgM, BioGX SARS-CoV-2, Abbott HIV Ag/AB Combo, Abbott HBsAg Qualitative, InBios SARS-CoV-2 IgM, NovaTek Parainfluenza Virus 1, 2, 3 IgG, Abbott Syphilis TP, BioFire FilmArray Gastrointestinal (GI) Panel, Perkin Elmer SARS-CoV-2 SWAB, FilmArray Respiratory Panel 2.1, Perkin Elmer SARS-CoV-2 SALIVA, AdviseDx SARS-CoV-2 IgM, ABBOTT M2000 SARS-CoV-2, Architect SARS-CoV-2 IgG

Sample Subtype :

RSV

Matrix Subtype :

Saliva, Serum SST, Nasopharyngeal swabs, Plasma EDTA K3

Available Clinical Data:

Date of Birth, COVID-19 Vaccination Date, First Dose, Reported Age, Change in Concomitant Medications?, Symptomology at the Time of Diagnosis, COVID-19 Vaccination Date, Second Dose, Date of Draw, Ethnicity, Vaccine manufacturer, Did the subject have acute respiratory distress syndrome, Did the subject develop pneumonia, Was the subject admitted to the intensive care unit (ICU)?, Date of Consent, Did the subject receive ECMO, Pre-Existing Medical Conditions, Time of Draw, In the 14 days prior to illness onset, did the subject have any of the following exposures?, Did subject receive a covid-19 vaccine booster?, Covid-19 vaccine booster Manufacturer, Country of Origin, Date sample frozen at -20 C or colder, City of Origin, Did the subject receive Mechanical Ventilation (MV) / Intubation?, Signs and Symptoms at the Time of Draw., Gender, Was the subject hospitalized?, Did the subject have another diagnosis or etiology for their illness?, If pregnant, which trimester?, Did the subject have an abnormal EKG, Did the subject receive a covid-19 vaccination, Concomitant Medications (if reported), Did the subject have an abnormal Chest X-ray, Date of onset of first symptoms, Time Frozen at -20 C or colder, Change in underlying medical conditions and/or risk behavior?, Date of Covid-19 vaccine booster

Sample Subtype :

RF

Matrix Subtype :

Plasma, Serum, Plasma CPD, Plasma EDTA K3

Available Tests:

Triglycerides, Rheumatoid Factor, Total Protein, Total Bilirubin, Chloride (Cl), Abbott Anti-HCV, Potassium (K), Abbott HIV Ag/AB Combo, Abbott HBsAg Qualitative, Albumin, Cholesterol, Direct Bilirubin, Phosphorus, RA, Calcium, Sodium (NA)

Sample Subtype :

RA

Matrix Subtype :

Plasma, Serum, Serum SST, Plasma EDTA K3

Available Clinical Data:

Date of Birth, Reported Age, Date of Draw, Ethnicity, Test Date (site reported results), Date of Consent, Autoimmune Disease Signs and Symptoms, Pre-Existing Medical Conditions, Date of Diagnosis, Time of Draw, Treatment History, Country of Origin, Date sample frozen at -20 C or colder, City of Origin, Gender, If pregnant, which trimester?, Did the subject receive a covid-19 vaccination, Concomitant Medications (if reported), Medication Start Date, Time Frozen at -20 C or colder, Site reported laboratory results

Available Tests:

Albumin, Serum or Plasma, Carbon Dioxide, Serum or Plasma, Rheumatoid Factor, Creatinine, Serum or Plasma, Protein Total, Serum/Plasma, Potassium, Serum or Plasma, Anion Gap, Glucose, Serum or Plasma, Aspartate Aminotransferase, Immunoglobulin G, Chloride, Serum or Plasma, ImmunoConcepts Hep-2000, Alanine Aminotransferase, Sodium, Serum or Plasma, NT-Pro BNP, Abbott Anti-HCV, Anti-Nuclear Antibodies (ANA), IgG by ELISA, Lex-RALatex, Abbott HIV Ag/AB Combo, AST, Abbott HBsAg Qualitative, Alkaline Phosphatase, ALT, Abbott Syphilis TP, Calcium, Serum or Plasma, Free Hemoglobin Serum, Urea Nitrogen, Serum or Plasma, RA, ANA, IgG by IFA, Bilirubin, Total, Serum or Plasma, Cyclic Citrullinated Peptide (CCP) Antibody, IgG

Sample Subtype :

Rosacea

Matrix Subtype :

Punch Biopsy Skin

Available Clinical Data:

Microscopic Description, Reported Age, Gross Description, Ethnicity, Sample Diameter (mm), Sample Location, Diagnosis (Oncology), Gender, Date of Procurement

Sample Subtype :

RPR

Matrix Subtype :

Serum

Sample Subtype :

Rubella, Rubella IgG

Matrix Subtype :

Plasma, Serum, Plasma EDTA K3

Available Tests:

Abbott Anti-HCV, Abbott HIV Ag/AB Combo, Abbott HBsAg Qualitative, Rubella IgG

Sample Subtype :

Screening Population

Matrix Subtype :

Saliva, Serum SST, Nasopharyngeal swabs, Plasma EDTA K3

Available Clinical Data:

pangoLEARN version, Date of Birth, Nucleotide Substitutions, Reported Age, SARS-CoV-2 PANGOLIN Lineage, Symptomology at the Time of Diagnosis, Date of Draw, Ethnicity, Vaccine manufacturer, Location of the Worker's Health Center, Percent of Genome Coverage, Nucleotide Insertions, Test Date (site reported results), SARS-CoV-2 Nextstrain Clade, Date of Consent, Amino Acid Substitutions, Amino Acid Deletions, Pre-Existing Medical Conditions, Time of Draw, In the 14 days prior to illness onset, did the subject have any of the following exposures?, Was the subject referred by a healthcare provider?, Country of Origin, Date sample frozen at -20 C or colder, City of Origin, Signs and Symptoms at the Time of Draw., Sequencing reference genome (GenBank Accession), Gender, If pregnant, which trimester?, Fever Temperature (F), Did the subject receive a covid-19 vaccination, Nucleotide Deletions, Concomitant Medications (if reported), Is the subject a healthcare worker?, Date of onset of first symptoms, Time Frozen at -20 C or colder, Site reported laboratory results

Available Tests:

Perkin Elmer SARS-CoV-2 SWAB, Perkin Elmer SARS-CoV-2 SALIVA, AdviseDx SARS-CoV-2 IgM, Architect SARS-CoV-2 IgG

Sample Subtype :

SLE

Matrix Subtype :

Plasma, Serum, Serum SST, Plasma EDTA K3

Available Clinical Data:

Date of Birth, COVID-19 Vaccination Date, First Dose, Reported Age, COVID-19 Vaccination Date, Second Dose, Date of Draw, Ethnicity, Rheumatology Condition, Stage of ATL, Test Date (site reported results), Date of Consent, Autoimmune Disease Signs and Symptoms, Pre-Existing Medical Conditions, Time of Draw, Date of Diagnosis, Treatment History, Country of Origin, Date sample frozen at -20 C or colder, City of Origin, Gender, If pregnant, which trimester?, State of Origin, Did the subject receive a covid-19 vaccination, Concomitant Medications (if reported), Time Frozen at -20 C or colder, Site reported laboratory results

Available Tests:

Genetic Systems HBsAg EIA 3.0, Albumin, Serum or Plasma, Carbon Dioxide, Serum or Plasma, Rheumatoid Factor, Creatinine, Serum or Plasma, Protein Total, Serum/Plasma, Potassium, Serum or Plasma, Anion Gap, Glucose, Serum or Plasma, Aspartate Aminotransferase, Immunoglobulin G, Chloride, Serum or Plasma, ImmunoConcepts Hep-2000, Alanine Aminotransferase, Sodium, Serum or Plasma, NT-Pro BNP, Abbott Anti-HCV, Anti-Nuclear Antibodies (ANA), IgG by ELISA, Abbott HIV Ag/AB Combo, AST, Abbott HBsAg Qualitative, Alkaline Phosphatase, ALT, Abbott Syphilis TP, Calcium, Serum or Plasma, Free Hemoglobin Serum, Urea Nitrogen, Serum or Plasma, ANA, IgG by IFA, Bilirubin, Total, Serum or Plasma, Cyclic Citrullinated Peptide (CCP) Antibody, IgG

Sample Subtype :

Sodium

Matrix Subtype :

Serum

Sample Subtype :

Chlamydia Trachomatis, Neisseria Gonorrhoeae, STI

Matrix Subtype :

Aptima Swab, Aptima Vaginal Swab, Urine

Available Tests:

Neisseria gonorrhoeae, Chlamydia trachomatis, Aptima BV Assay

Sample Subtype :

Group B Streptococci, Group A Strep. Sym., Group G Streptococci  , Group C Streptococci

Matrix Subtype :

Throat Swab, Serum SST, Nasopharyngeal swabs, Nasal Swab, Plasma EDTA K3

Available Clinical Data:

Date of Birth, Reported Age, Date of Draw, Ethnicity, Date of Consent, Pre-Existing Medical Conditions, Time of Draw, In the 14 days prior to illness onset, did the subject have any of the following exposures?, Country of Origin, Date sample frozen at -20 C or colder, City of Origin, Signs and Symptoms at the Time of Draw., Gender, If pregnant, which trimester?, Did the subject receive a covid-19 vaccination, Concomitant Medications (if reported), Date of onset of first symptoms, Time Frozen at -20 C or colder

Sample Subtype :

Signs/Symptoms Hep.

Matrix Subtype :

Plasma, Serum SST, Plasma EDTA K3

Available Clinical Data:

Date of Birth, One or more of the following within 4 weeks of enrollment:, Date of Draw, Time of Centrifugation, Ethnicity, Subject is 18 years of age or older at the time of enrollment and blood draw, One or more of the following:, Date of Consent, Time of Draw, Country of Origin, City of Origin, Gender, Two or more of the following within 4 weeks of enrollment:, Date of onset of first symptoms

Available Tests:

Bio-Rad Geenius HIV 1/2 Supplemental Assay, Liaison CMV IgM, Abbott Anti-HCV, Liaison CMV IgG, HIV-1 Viral Load, Abbott HIV Ag/AB Combo, Abbott HBsAg Qualitative, Abbott Syphilis TP, Architect Anti-HAV IgG, Architect Anti-HAV IgM

Sample Subtype :

Syphilis Prim. UT, Syphilis Lat. T, Syphilis

Matrix Subtype :

Plasma, Serum, Serum SST, Plasma EDTA K3

Available Clinical Data:

Syphilis Test Result, Date of Birth, Syphilis Test Manufacturer, Date of Draw, Time of Centrifugation, Ethnicity, Syphilis Test Type, Syphilis Treatment Status, Date of Consent, Time of Draw, Date of Diagnosis, Site Reported Syphilis RPR Result (flocculation), Country of Origin, City of Origin, Gender, Syphilis Test Date, Syphilis Test Method, If pregnant, which trimester?, Syphilis Stage of Infection, Time Frozen at -20 C or colder

Available Tests:

LIAISON XL SARS-CoV-2 S1/S2, Bio-Rad Geenius HIV 1/2 Supplemental Assay, Liaison CMV IgM, Abbott Anti-HCV, Liaison SARS-CoV-2 IgM, Liaison CMV IgG, HIV-1 Viral Load, Abbott HIV Ag/AB Combo, Abbott HBsAg Qualitative, Abbott Syphilis TP, V.D.R.L Test, Syphilis RPR, AdviseDx SARS-CoV-2 IgM, Architect SARS-CoV-2 IgG

Sample Subtype :

TDA

Matrix Subtype :

Saliva, WB EDTA K3, WB PAXgene RNA, Plasma, Serum, WB Plasma, Whole Blood, Urine, Plasma EDTA K3

Available Clinical Data:

Date of Draw, If pregnant, which trimester?

Available Tests:

Bordetella pertussis Antibody, IgG by ELISA, Chikungunya Differenciation, DiaSorin Zika IgM, Influenza A Virus Antibody IgM, Mycoplasma Pneumoniae Antibody IgM, Dengue Differenciation, Aptima Zika Virus Assay - Urine, InBios WNV IgM, B. pertussis Ab, IgA by ELISA, EuroImmun Anti-Chikungunya Virus IgG, InBios Zika IgM Capture, Mycoplasma Pneumoniae Antibody IgG, DiaPro Zika Virus IgG, Aptima Zika Virus Assay - Serum, InBios Anti-Dengue IgM, InBios Anti-Dengue IgG, EuroImmun Anti-Chikungunya Virus IgM, B. pertussis Ab, IgM by ELISA, Influenza A Virus Antibody IgG, ZIKV Detect 2.0 IgM Capture ELISA, LIAISON Rubella IgG, Haemophilus influenzae b Antibody, IgG

Sample Subtype :

Zika, Toxoplasmosis, Dengue, Acute Chikungunya, TDS, TDSPL, Malaria, Leptospirosis, Chikungunya

Matrix Subtype :

Saliva, WB EDTA K3, Aspirate, WB PAXgene RNA, Plasma, Serum, WB EDTA K2, Plasma CPDA-1, WB Plasma, Whole Blood, Plasma ACD, Serum SST, Amniotic Fluid, Urine, Slides, Plasma Na Citrate, Plasma EDTA K3, Human Cord Serum, Umbilical Cord Plasma

Available Clinical Data:

Does the patient have yellow fever vaccination documentation?, Date of Birth, Site Reported Dengue IgM, Reported Age, Symptomology at the Time of Diagnosis, Date of Draw, Time of Centrifugation, Ethnicity, Does the patient have diagnostic testing?, Subject is 18 years of age or older at the time of enrollment and blood draw, Date of Consent, Tropical Disease Other Signs and Symptoms, Malaria Diagnostics Test Method Used, Pregnant?, Pre-Existing Medical Conditions, Time of Draw, Country of Origin, City of Origin, Suspected Tropical Disease, Signs and Symptoms at the Time of Draw., Malaria Test Date, Gender, Was the subject hospitalized?, Infection Status, If pregnant, which trimester?, State of Origin, Suspected Tropical Disease:, Malaria Species, Fever Temperature (F), Subject has high fever and at least two tropical disease signs and symptoms, Tropical Disease Signs and Symptoms, Date of onset of first symptoms, Patient Has Documentation For Yellow Fever Vaccination, Time Frozen at -20 C or colder, Malaria Test Result

Available Tests:

BinaxNOW Malaria, Trypanosoma cruzi, IgG, Bordetella pertussis Antibody, IgG by ELISA, C. psittaci IgG, EuroImmun Anti-Dengue Virus IgM, Malaria Detection and Speciation, Qualitative by RT PCR, Chikungunya Differenciation, C. pneumoniae IgG, DiaSorin Zika IgM, Influenza A Virus Antibody IgM, Mycoplasma Pneumoniae Antibody IgM, Dengue Differenciation, Aptima Zika Virus Assay - Urine, DiaPro Anti-Dengue Virus IgM, Adenovirus Antibody, Serum, C. psittaci IgM, Influenza B Virus Antibody IgM, InBios Dengue NS-1, HAV RT-PCR, UltraQual 1000 2x, InBios WNV IgM, Temporary Zika NAT, Abbott Anti-HCV, C. trachomatis IgG, C. trachomatis IgM, EuroImmun Anti-Chikungunya Virus IgG, InBios Zika IgM Capture, Mycoplasma Pneumoniae Antibody IgG, DiaPro Zika Virus IgG, Aptima Zika Virus Assay - Serum, InBios Anti-Dengue IgM, InBios Anti-Dengue IgG, HIV-1 Viral Load, DiaPro Anti-Chikungunya IgG, Abbott HIV Ag/AB Combo, EuroImmun Anti-Chikungunya Virus IgM, Abbott HBsAg Qualitative, InBios Chikungunya IgG, InBios WNV IgG, C. pneumoniae IgM Titer, EuroImmun Anti-Dengue Virus IgG, DiaPro Zika Virus IgM, InBios Chikungunya IgM, Abbott Syphilis TP, Influenza A Virus Antibody IgG, Influenza B Virus Antibody IgG, DiaPro Anti-Dengue Virus IgG, ZIKV Detect 2.0 IgM Capture ELISA, Dengue Virus (1-4) Subtype by PCR, EuroImmun Anti-Zika Virus IgG, Trypanosoma cruzi, IgM, Leptospira Antibody, IgM by Dot Blot, EuroImmun Anti-Zika Virus IgM, Zika MAC-ELISA, DiaPro Anti-Chikungunya IgM, EuroImmun Anti-WNV IgG, Aptima Zika Virus Assay - Plasma, Haemophilus influenzae b Antibody, IgG, Chikungunya by PCR, COBAS AmpliPrep/COBAS TaqMan HIV-1 Test v2.0, WNV-PCR: (Roche WNV-PCR), Syphilis

Sample Subtype :

TPO

Matrix Subtype :

Serum

Available Tests:

Thyroglobulin, Thyroid Peroxidase

Sample Subtype :

Chronic Lyme Disease, Lyme Disease, Tick-Borne

Matrix Subtype :

WB EDTA K3, WB PAXgene RNA, Plasma, Serum, Whole Blood, Serum SST, Plasma EDTA K3

Available Clinical Data:

Date of Birth, Lipemia (laboratory evidence), Reported Age, Date Treatment or Medication 1 Began, Visit Number, Date of Draw, Time of Centrifugation, Ethnicity, Date Treatment or Medication 3 Ended, Sample Hemolysis Level (Qualtex Color Comparator), Date Treatment or Medication 2 Ended, Subject is 18 years of age or older at the time of enrollment and blood draw, What medication(s) is the subject currently taking?, Height (cm), Date of Tick Bite, Date of Consent, Current Medications or Treatments 2, Pregnant?, Date of Diagnosis, Time of Draw, If yes, select confirmatory lab results, Treatment History, Clinical Observations, Current Medications or Treatments 3, Storage Start Date, Specify Tick-Borne illness, Tick Exposure Site, Country of Origin, Confirmatory lab results (Tick Born), Signs and Symptoms at the Time of Draw., Date Treatment or Medication 1 Ended, Where was the patient exposed?, Gender, Location on body of tick exposure, If pregnant, which trimester?, Concomitant Medications (if reported), Start time of blood processing, Current Medications or Treatments 1, Storage Start Time, Medication Start Date, Weight, kg, Date of onset of first symptoms, Date Treatment or Medication 3 Began, Date Treatment or Medication 2 Began, Time Frozen at -20 C or colder, Signs and Symptoms (Tick Born Disease)

Available Tests:

Borrelia Species by PCR (Lyme Disease), Ehrlichia chaffeensis Ab, IgG by IFA, Ehrlichia chaffeensis Ab, IgM by IFA, DiaSorin Lyme, Anaplasma phagocytophilum (HGA) Ab, IgM, Borrelia burgdorferi Antibodies, IgG by Immunoblot, Borrelia burgdorferi Ab, Total ELISA, Babesia microti Ab IgG by IFA, Immunetics C6 B.burgdorferi Lyme, Rickettsia typhi (Typhus Fever) Antibody, IgM by IFA, Babesia microfi Ab IgM by IFA, Borrelia burgdorferi Antibodies, IgM by Immunoblot, Anaplasma phagocytophilum (HGA) Antibody, IgG, Rickettsia typhi (Typhus Fever) Antibody, IgG by IFA

Sample Subtype :

TORCH Negative

Matrix Subtype :

Plasma, Plasma Na Citrate

Sample Subtype :

Total Bilirubin

Matrix Subtype :

Serum

Sample Subtype :

Total Protein

Matrix Subtype :

Serum

Available Tests:

Total Protein

Sample Subtype :

BUP, 6AM

Matrix Subtype :

Urine

Available Tests:

Buprenorphine - Urine, 6-Acetylmorphine

Sample Subtype :

Toxo IgG, Toxo IgM

Matrix Subtype :

Serum, Plasma EDTA K3

Available Clinical Data:

Toxoplasma Gondii IgM (Site Reported CLIA), Infection Status, Signs and Symptoms (Toxoplasmosis)

Available Tests:

Toxoplasma gondii Ab, IgM, Toxoplasma gondii Antibody, IgG

Sample Subtype :

Triglycerides

Matrix Subtype :

Serum

Available Tests:

Triglycerides

Sample Subtype :

Tropical Disease

Matrix Subtype :

WB EDTA K3, Plasma, Serum SST, Plasma EDTA K3

Available Clinical Data:

Does the patient have yellow fever vaccination documentation?, Date of Birth, Reported Age, Date of Draw, Time of Centrifugation, Ethnicity, Date of Consent, Time of Draw, Country of Origin, Suspected Tropical Disease, Gender, If pregnant, which trimester?, State of Origin, Tropical Disease Signs and Symptoms, Date of onset of first symptoms, Patient Has Documentation For Yellow Fever Vaccination, Time Frozen at -20 C or colder

Sample Subtype :

Ulcerative Colitis

Matrix Subtype :

Serum SST, Plasma EDTA K3

Available Clinical Data:

Date of FCP Result, If on medications, for how long? (days), Date of Birth, Ethnicity (hispanic specific), Reported Age, Date of Draw, Ethnicity, Prior Biologic Treatment History, Date of CRP result, Subject is 18 years of age or older at the time of enrollment and blood draw, What medication(s) is the subject currently taking?, Most recent Fecal Calprotectin (FCP) result, Date of Consent, Time of Draw, Date of Diagnosis, Gastroenterology Condition, Disease Status at time of sample collection, Clinical Symptom Score (CD: CDAI), Country of Origin, Date sample frozen at -20 C or colder, City of Origin, Most recent C-reactive protein (CRP) result, Gender, Time Frozen at -20 C or colder, Is the subject currently on medications?

Sample Subtype :

UTI

Matrix Subtype :

Urine

Available Clinical Data:

Date of Draw, Identity of Bacterial Infection, UTI Bacteria Concentration (CFU) (Site Reported), Infant Age, Country of Origin, Gender

Available Tests:

Urine Culture, Chlamydia trachomatis

Sample Subtype :

VARPL

Matrix Subtype :

Plasma, Plasma Na Citrate

Available Tests:

Abbott Anti-HCV, Abbott HIV Ag/AB Combo, Abbott HBsAg Qualitative

Sample Subtype :

HCV/HIV, HBV/HCV, HBV/HCV/HIV, HBV/HIV

Matrix Subtype :

Plasma

Available Clinical Data:

Sample Hemolysis Level (Qualtex Color Comparator)

Available Tests:

Abbott Anti-HCV, Abbott HIV Ag/AB Combo, Abbott HBsAg Qualitative

Sample Subtype :

Vitamin D

Matrix Subtype :

Serum

Available Tests:

Vitamin D-25

Sample Subtype :

VZV, VZVPL

Matrix Subtype :

Plasma, Serum, Plasma Na Citrate, Plasma EDTA K3

Available Clinical Data:

Date of Birth, Anatomical location(s) of fluid filled blisters., VZV IgM Test Result (Site Reported), Date of onset of first symptoms, Signs and Symptoms (Varicella Zoster)

Available Tests:

VZV IgG, Varicella-Zoster Virus Antibody, IgM, Abbott Anti-HCV, Abbott HIV Ag/AB Combo, Abbott HBsAg Qualitative, Epstein-Barr Virus Ab to Viral Capsid Antigen, IgG, Varicella-Zoster Virus Antibody, IgG

Sample Subtype :

WNV

Matrix Subtype :

Plasma, Serum, Plasma CPD, Plasma EDTA K3

Available Clinical Data:

Date of Draw

Available Tests:

InBios WNV IgM, InBios WNV IgG, WNV-PCR: (Roche WNV-PCR)

Sample Subtype :

Candida

Matrix Subtype :

Aptima Vaginal Swab

Available Tests:

Aptima Trichomonas vaginalis Assay, Candida Vaginitis, Gardnerella vaginalis